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Abstract 
The pancreas is a glandular organ composed of endocrine and exocrine compartments. 
Integrins are cell adhesion molecules that connect cells to the extracellular matrix (ECM). 
Integrins modulate a variety of cellular effects, yet their mechanism of action in the 
developed pancreas is not well understood. Fibrin is a provisional ECM protein that 
contains ligands for integrin receptors. Fibrin is capable of supporting islet health, but it is 
unclear how fibrin exerts its effects. The objective of this thesis is to understand the role of 
integrin receptors on in vivo pancreatic cell function, survival, and proliferation. In 
addition, this thesis investigates how fibrin promotes pancreatic cell maturation, function, 
and survival in culture. Pancreatic tissues from transgenic adult mice lacking β1 integrin 
were harvested at 4 and 7 weeks post-induction. The rat insulinoma cell line, INS-1, and 
human fetal-islet epithelial cells were cultured on tissue culture polystyrene plates or with 
fibrin in two or three dimensions for up to 4 weeks, then collected for analyses. 
β1 integrin knockout mice demonstrated significant glucose intolerance and reduced 
glucose-stimulated insulin secretion (GSIS). β1 integrin knockout mice also had reduced 
beta cell expression of Pdx-1 and Nkx6.1, as well as reduced acinar cell expression of 
amylase, lipase and Reg-II. Alternatively, to investigate the effects of supplementing 
pancreatic cells with ECM in culture, INS-1 cells and human fetal islet-epithelial clusters 
were cultured with fibrin. Culturing these cells with fibrin led to significantly increased 
integrin αvβ3 expression. INS-1 cells cultured with fibrin had significantly increased GSIS 
and significantly reduced caspase-3 cleavage, which was reversed by antibody blockade of 
integrin αvβ3. Human fetal islet-epithelial cells cultured with fibrin had increased PDX-1 
expression, which was mediated, in part, by the mTOR/p70s6k pathway. Transplantation of 
fibrin-mixed human fetal-islet epithelial cells led to maintained differentiation and 
improved graft vascularization. Integrins are essential for maintaining glucose homeostasis 
and acinar cell function. Furthermore, culturing pancreatic cells with fibrin leads to 
increased integrin expression and improved cell maturation, function, survival and 
proliferation. Understanding how integrins modulate the pancreas and associated islet cells 
will lead to more effective protocols for the culture of isolated islets.  
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1.1 Significance of this PhD thesis 
Cell-based therapies for diabetes are currently the most promising treatment modality 
to render diabetics insulin-independent. Universal availability of these techniques are 
limited by a comprehensive understanding of islets. Integrins, a group of cell adhesion 
molecules, are critical for integrating the extracellular environment with interior 
cellular processes. However, the mechanisms behind these processes in the pancreas 
are not completely understood. My studies are significant because I demonstrate the 
necessity of cell-extracellular matrix (ECM) interactions in maintaining islet cell health 
and provide insight on improving cell-based therapies for diabetes. 
1.2 Pancreas anatomy and development 
The pancreas is a glandular organ that regulates blood glucose as well as aids in food 
digestion. It lies inferior to the stomach, attaches to the duodenum via the pancreatic 
duct and is vascularized via the superior mesenteric artery and vein. The pancreas itself 
consists of exocrine and endocrine tissue, the latter composing only 2-3% of the total 
pancreas mass. The exocrine compartment is made up of acinar cells that produce 
digestive enzymes and pH neutralizing bicarbonate through an intricate network of 
ducts that lead to the duodenum. The endocrine pancreas is composed of scattered cell 
clusters known as the Islets of Langerhans, or more conventionally, islets. Islets are 
made up of cells that secrete insulin (beta cells), glucagon (alpha cells), somatostatin 
(delta cells), pancreatic polypeptide (PP cells) and ghrelin (epsilon cells). In human 
islets, beta and alpha cells make up most of the islet (54% and 36%, respectively), with 
a few delta, epsilon and PP cells [1]. Meanwhile, mouse islets are primarily made up of 
beta cells (~87%), where alpha cells (7%) make up the periphery of the islet, and a few 
delta, epsilon and PP cells [1]. The role of beta cells is to secrete insulin when blood 
glucose becomes too high. Subsequently, this insulin will stimulate insulin receptors on 
hepatocytes, adipocytes and myocytes. Stimulation of the insulin receptor allows 
glucose uptake and promotes glycogen or fatty acid synthesis. Conversely, alpha cells 
secrete glucagon in response to low blood glucose, which will stimulate the liver to 
produce glucose.  
Development of the pancreas is very complex and requires well-timed expression of 
transcription factors and signaling pathways. The pancreas is derived from the 
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endoderm germline during development. It begins budding at embryonic day 8.5 in the 
mouse [2] or gestational day 25 in humans [3]. A transcription factor essential to the 
development of definitive endoderm is the Sry-related HMG box 17 protein (Sox17) 
[4]. Two parts of this definitive endoderm evaginate as primitive pancreatic buds, and 
express the transcription factors pancreatic duodenal homeobox 1 (Pdx1) and pancreas 
transcription factor 1a (Ptf1a) [5], which are essential for pancreatic development. 
Distinct signaling pathways dictate the specific expression and repression of 
transcription factors, which induce transient expression of neurogenin3 (Ngn3) and 
initiate endocrine cell differentiation [6]. Microarray analysis of Ngn3 knockout mice 
shows that Ngn3 regulates a large subset of genes required for progression of progenitor 
cells into endocrine cells [7]. Neurogenic differentiation 1 and islet-1 are downstream 
of Ngn3 and have been explicitly shown to be essential for endocrine lineage 
determination [8, 9]. These endocrine precursor cells then split into separate 
differentiated endocrine lineages; alpha, beta, delta, epsilon and PP cells, and begin to 
organize into islets by embryonic day 16 (for a full review on pancreatic development 
see [3, 10]). A set of transcription factors including Pdx1, Nk2 homeobox 2 and Nk6 
homeobox 1 (Nkx6.1), Paired box gene 4 and 6, and v-maf avian musculoaponeurotic 
fibrosarcoma homolog A (MafA) are required not only for beta cell development, but 
also for beta cell maturation and function (reviewed in [11]). If there is a defect during 
pancreatic development or the adult pancreas is unable to regulate blood glucose 
sufficiently, Diabetes Mellitus (DM) occurs. 
1.3 Diabetes Mellitus and treatment options 
Endocrine cells make up only 2-3% of cells of the total pancreas mass. This population 
plays a critical role in regulating glucose homeostasis. Importantly, impaired glucose 
homeostasis is associated with DM; a condition of absolute or relative insulin 
deficiency. Type 1 DM refers to the autoimmune condition whereby host T cells attack 
beta cells of the pancreas, which results in a state where little to no insulin is produced. 
Type 2 DM has a multi-factorial pathogenesis, whereby initial compensatory insulin 
production/secretion is insufficient to reduce blood glucose due to peripheral insulin 
resistance, reduced beta cell mass, and increased body weight. In both conditions, the 
eventual treatment regimen is daily exogenous insulin injections aimed to maintain 
blood glucose levels normalized to that of unaffected individuals. This regimen has 
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significantly lowered the mortality and morbidity rates of DM. However, it has been 
suggested that the blood glucose variability under exogenous insulin treatment may 
contribute to long-term complications in diabetic patients such as cardiomyopathies, 
neuropathies or retinopathies [12, 13]. Therefore, it is imperative that researchers 
discover a curative therapy that leads to physiologic glycemic control, preventing the 
need for exogenous insulin and reducing long-term complications.  
One proposed DM cure is islet transplantation, a cell-based therapy that removes islets 
from a donor pancreas and transplants them into a diabetic individual. Pioneered at the 
University of Alberta, the Edmonton protocol for islet transplantation uses a 
glucocorticoid-free immunosuppression regimen as islets are transplanted into type 1 
DM patients [14]. Patients are initially insulin-independent after transplantation, but 
most revert back to insulin injections within 5 years to maintain glycemia due to graft 
failure [15]. This graft failure is associated with increased islet cell death and loss of 
islet cell function. As such, islet transplantation techniques need to be improved so that 
patients can be insulin-independent for their entire lifetimes. One limitation in 
mastering these techniques is the unavailability of human islets [16]. Therefore, 
methods that can increase the number of islets (specifically beta cells) and improve the 
survival and function of existing islets will be critical for the success of islet 
transplantation. However, ex vivo islet mass expansion has been a difficult task, since 
senescence and loss of islet integrity and insulin expression occur after extended culture 
[17]. Moreover, the islet micro-environment plays an important role in maintaining islet 
health and the mechanisms behind cell-ECM interactions are largely unknown [18]. In 
particular, integrins are the major cell receptor type that integrates signals from the 
ECM to the interior of the cell.  
1.4 Integrin receptors 
Integrins are a class of cell and extracellular matrix (ECM) binding proteins that 
integrate the exterior environment to the inside of the cell. Twenty-four combinations 
of α and β integrin subunits have been discovered, each with a unique range of affinity 
to different ligands (Figure 1-1) [19]. Integrins have been implicated in a large variety 
of cellular processes in almost all cell types [20]. They can be categorized based on 
their ligand of preference. For example, α1, α2, α10, or α11 associate with β1 to bind   
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Figure 1-1 Mammalian integrin receptors and their preferential binding partners. 
Integrin β1 is the most promiscuous receptor, associating with α1, α2, α3, α4, α5, α6, 
α7, α8, α9, α10 and α11 to bind with many different ligands. β2 integrin primarily binds 
to cell surface receptors and associates with αL, αM, αX, αD. The same is true for αEβ7. 
Integrin αv pairs with β3, β5, β6 and β8 to bind to Arg-Gly-Asp domains, while β4 
integrin binds to laminins with α6 integrin [19-22]. 
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to collagen motifs [21]. Meanwhile, αv associates with β3, β5, β6 or β8 to preferentially 
bind to fibronectin type proteins that contain Arg-Gly-Asp (RDG) domains in their 
structure (Figure 1-1) [22]. It should be noted, however, that integrins are not restricted 
to binding only one ligand and have low affinity to many ligands [22]. Before integrins 
can be bound by ligands, integrins must be activated to a high-affinity conformation by 
a process termed inside-out signaling [23]. Inside-out signaling is orchestrated by 
proteins such as talin [24, 25] and those of the kindlin family [26, 27], which bind to 
the intracellular cytoplasmic tails of integrins. Once integrins are in this open, high-
affinity state, binding of ligands to integrin receptors leads to a cascade of events, 
collectively known as outside-in signaling. The clustering of ligand-bound receptors 
into focal complexes or adhesions causes significant downstream effects including 
recruitment and activation of second messengers and signaling pathways [28]. Focal 
adhesion kinase (FAK) is an important protein that interact with integrin-binding 
proteins to mediate intracellular signaling pathways such as mammalian target of 
rapamycin (mTOR), v-akt murine thymoma viral oncogene (AKT) and extracellular 
signal-regulated kinase 1/2 (ERK1/2) [29-31]. Integrin-linked kinase (ILK) is another 
key protein recruited to link integrins to the cytoskeleton and modulate cell migration 
[32]. Knockout studies indicate that ILK plays a role in apoptosis [33, 34] and 
proliferation via AKT and p27 [35, 36]. Many other proteins are involved in outside-in 
signaling that mediate cellular effects, but it is outside the scope of this thesis to discuss 
them. 
1.4.1 Integrin receptors and signaling pathways in the pancreas 
Despite being ubiquitous, the expression of integrins in each organ and cell type varies 
tremendously. Wang and colleagues demonstrated that adult human islets express 
integrins α3, α5, αv and β1 [37]. Furthermore, endocrine cells of the developing human 
pancreas commonly express integrins α3, α5, and α6β1 [38]. Integrins αvβ3 and αvβ5 
are also expressed in early human pancreatic progenitors and play a major role in 
adhesion and migration [39]. In the rodent pancreas, the integrin receptors α3, α5, and 
α6β1 are localized to duct and islet cells [40]. Meanwhile, another report demonstrated 
expression of integrins α6 and α3 in acinar cells, α6β4 in the duct, α6β1 in acinar and 
ductal cells, and α3β1 in all pancreatic cells [41]. Indeed, the most promiscuous and 
well-studied integrin is β1. In human fetal pancreatic cells and adult rat islets, β1 
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integrin is critical for the maintenance of cell adhesion, survival and insulin expression 
[38, 40]. In the developing mouse pancreas, β1 integrin regulates beta cell expansion 
[42]; whereas in the developed mouse pancreas, it is critical for maintaining glucose 
homeostasis, beta cell proliferation and survival [43; Chapter 2], as well as exocrine 
tissue architecture and function [44, 45; Chapter 3]. In fact, when β1 integrin is ablated 
in mouse beta cells, there is a significant reduction in the number of beta cells and 
dysregulation in the expression of genes associated with cell cycle progression [42]. In 
addition, integrins α1, α2, α3, α4, α5, α6, αv, β1, β3, and β4 have abnormal expression 
in pancreatic cancer (reviewed in [46]). β1 integrin has also been shown to play an 
important role in the invasiveness of different pancreatic carcinoma cell lines [47]. 
Taken together, these studies demonstrate that the integrins, especially β1 integrin, play 
a critical role in maintaining pancreatic endocrine and exocrine health.  
It was previously mentioned that integrin receptor activation mediates intracellular 
signaling pathways in order to affect cellular processes. One of the first molecules to 
be activated after integrin stimulation is FAK. In beta cells, loss of FAK leads to 
decreased beta cell survival and proliferation, along with reduced activation of AKT 
and ERK1/2 [48]. Both AKT and ERK1/2 have important roles in regulating beta cell 
function, proliferation and survival. In general, AKT is critical for the regulation of cell 
growth, survival, and proliferation (reviewed in [49]). In beta cells, activation of AKT 
leads to cell cycle progression by regulating cyclin dependent kinase 4, cyclin D1, 
cyclin D2 and p21 [50]. Increasing active AKT during development significantly 
increases beta cell replication and beta cell mass [51]. Similar to AKT, ERK1/2 
activation mediates cell proliferation and survival in multiple cells types [52]. However, 
phosphorylation of ERK1/2 in beta cells is sufficient to stimulate insulin expression 
[53]. In vitro, ERK1/2 activation leads to phosphorylation of Pdx-1 and MafA to 
promote beta cell function [54]. In this manner, ERK1/2 plays multiple roles in beta 
cells, including promoting cell survival, proliferation and function. Meanwhile, AKT 
activation is important for beta cell survival and proliferation.  
Another intracellular signaling pathway important in the pancreas is the mTOR 
pathway. Nutrient sensing has been described as one of the important roles of mTOR 
(reviewed in [55]). In beta cells, however, two roles of mTOR have been described. 
Firstly, mTOR pathway stimulation promotes beta cell growth and proliferation [56]. 
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Alternatively, chronic activation of the mTOR pathway activity (by high glucose) leads 
to inhibition of AKT, and eventually beta cell apoptosis [57]. Thus, an important 
balance of mTOR stimulation is required to maintain proper beta cell survival and 
growth. In order for integrins to activate any of these intracellular signaling pathways, 
ligand stimulation is required. The primary ligands of integrin receptors are the proteins 
of the ECM. 
1.5 The pancreatic extracellular matrix 
ECM proteins present in the pancreas include collagen I, collagen IV, fibronectin, and 
laminin [58]. Many of these ECM proteins are components of the basement membrane, 
which is necessary for the maintenance of islet architecture and acinar cell clusters. The 
basement membrane acts as a scaffold for cell attachment and modulates endocrine cell 
survival, insulin secretion, proliferation, differentiation, and migration (reviewed in 
[58]). However, over production of ECM adversely affects the exocrine pancreas, 
potentially causing fibrosis, inflammation, as well as cancer (reviewed in [59]). 
Therefore, it appears that an optimal amount of ECM protein is essential for pancreas 
survival and function. Two prominently expressed ECM proteins in the pancreas are 
collagen I and collagen IV. 
1.5.1 Collagen I and IV 
In the native rat and human pancreas, collagen I is present in perivascular islet 
capillaries. However, the human pancreas also contains collagen I immunoreactivity in 
and around islets [60]. Therefore, numerous studies have investigated whether in vitro 
replacement of collagen I could maintain islet differentiation, proliferation, survival, 
and function [61-73]. In particular, culturing isolated rat islets in a collagen I matrix led 
to a significant reduction in islet cell death after 5 days [61] and improved glucose-
stimulated insulin secretion (GSIS) after 11 days [62]. Using the rat insulinoma cell 
line, INS-1, our research group has found that INS-1 cells exposed to collagens I or IV 
demonstrated significant increases in cell adhesion, spreading, and proliferation when 
compared to cells cultured on either fibronectin, laminin, or tissue-culture polystyrene 
[63]. Perturbation of α3β1 integrin interactions with collagen I and IV led to 
significantly decreased FAK, ERK1/2, and Akt phosphorylation, and significantly 
increased cleaved caspase-3 levels. This indicates that binding between collagen I and 
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IV to α3β1 integrin is essential to support the survival of INS-1 cells, human fetal 
pancreas, and human adult islets [63, 64]. Analysis of canine islets cultured on collagen 
I showed a significant improvement in adhesion, GSIS, and insulin content, all while 
significantly reducing islet cell death when compared to controls [65]. Likewise, human 
adult islets cultured on a collagen I matrix exhibited significantly improved insulin 
response to acute glucose challenge after 3 days and were viable for longer than 8 weeks 
[66]. Meanwhile, studies in human fetal pancreatic islet cells demonstrated that β1 
integrin blockade resulted in significantly decreased expression of essential islet genes 
(insulin, glucagon and PDX-1), along with down-regulation of the FAK/mitogen-
activated protein kinase (MAPK)/ERK signaling cascade when cells were plated on 
collagen I gels [67]. Islet survival, however, was significantly increased when isolated 
islets were cultured on a combination of collagen IV, laminin, and fibronectin when 
compared to just collagen I alone [68]. Furthermore, adding a combination of soluble 
laminin or fibronectin to the culture media of islets cultured on collagen I prevented 
islet-epithelial transformation [69]. Culturing neonatal islets on a collagen I gel led to 
significantly increased cell proliferation and expansion of c-Kit-expressing cells, which 
was maintained for up to 8 weeks [70]. Past work has also shown that collagen I 
supports differentiation and maturation of pancreatic precursor cells into beta cells 
when cultured in 3D polyethylene glycol hydrogels [71]. The use of a collagen I-based 
3D entrapment method improved adult islet morphology, viability, and function with 
no defects in oxygen consumption when compared to controls [72]. Collagen I gels 
supplemented with other ECM proteins also supported long-term human islet culture 
demonstrating similar insulin stimulation indexes to freshly isolated islets [73]. In 
summary, these results suggest that collagen I plays a role in regulating islet cell 
proliferation, function, and survival. 
Another collagen that has an essential role in the basement membrane surrounding islets 
is collagen IV [74]. Many studies have investigated the importance of collagen IV in 
vivo, and as a supportive gel in vitro. Injecting streptozotocin (STZ) into neonatal 
Wistar rats had a significant impact on glucose homeostasis, and after recovery, 
collagen IV expression did not recover to normal, suggesting that collagen IV may be 
required to facilitate beta cell growth and function [75]. Collagen IV is also crucial for 
beta cell motility and insulin secretion via α1β1 integrin [76]. Likewise, collagen IV 
improved adult beta cell insulin secretion in an ERK-dependent manner [77], which 
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likely occurs through increased fibroblast growth factor receptor 1 protein expression 
[78]. Culturing islets on collagen IV also prevented apoptosis when compared to 
controls [68]. We have demonstrated that collagen IV improves human islet and INS-1 
cell adhesion, spreading, survival, and function by interacting with integrin α3β1 [63]. 
However, another immortalized beta cell line, RIN-5F, showed minimal changes in cell 
adhesion and proliferation when cultured on plates coated with either collagen I or IV 
compared to controls [79]. Using encapsulation methods, collagen IV was able to 
improve GSIS, and demonstrated a synergistic improvement when mixed with laminin 
[80]. Three dimensional culture of human adult islets in collagens I and IV led to higher 
insulin gene expression compared to fibronectin or laminin [81]. Another 3D culture 
system was developed using poly(lactic-co-glycolic acid)-collagen hybrid scaffolds, 
which supported RIN-5F cell proliferation, function, and differentiation [82]. These 
studies indicate that collagen I and collagen IV are able to improve beta cell function, 
proliferation, and survival after short term culture. 
1.5.2 Collagen-associated islet transdifferentiation 
Despite the observed improvements in islet health associated with collagen culture, 
reports show that islets cultured on collagen gels end up losing their insulin secretion 
function, express markers of ductal cells (CK-19), and form cystic structures [83, 84]. 
When isolated adult male Sprague-Dawley islets were cultured in collagen gels 
(produced from rat tails) with growth factors, there was a time-dependent decrease in 
insulin secretion as well as increased CK-19 expression [85]. These results suggest that 
collagen may not be able to maintain the differentiated state of islets, and instead 
supports the transdifferentiation of islets to a ductal-cell phenotype. Indeed, a similar 
finding was observed when culturing isolated adult human [83] and canine [84] islets 
in three-dimensional rat tail collagen gels. Development of these duct-like epithelial 
cystic structures is initially associated with a significant increase in islet cyclic 
adenosine monophosphate, c-Jun N-terminal kinase (JNK) signaling, and cleaved 
caspase-3 levels, with reduced ERK/Akt signaling, giving a net effect of increased 
apoptosis. Following ductal-like structure formation, there is a consequent reduction in 
JNK signaling and cleaved caspase-3 levels with an increase in ERK/Akt signaling 
resulting in duct-like cell proliferation [69, 86]. Interestingly, this transdifferentiation 
could be reduced, in a dose-dependent manner, by the addition of transforming growth 
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factor β [87]. Another research group cultured human islets in a collagen matrix and 
showed a concentration-dependent effect of epidermal growth factor on islet 
transdifferentiation via the AKT and ERK signaling pathways [88]. As well, when 
collagen I-cultured islet-derived duct-like epithelial cells were treated with the islet 
neogenesis-associated protein, they re-differentiated back to islet-like structures, 
including all four endocrine cell types [89]. Conversely, culturing human islets with 
adhered collagen molecules did not lead to duct cell transdifferentiation, but rather to 
maintenance of insulin gene expression [83]. This suggests that the negative effects of 
collagen culture on islets can be mediated by the addition of growth factors, but that 
collagen culture by itself is limited in its usefulness in promoting islet health. In 
contrast, a provisional ECM protein that does not promote islet transdifferentiation 
during culture is fibrin. 
1.6 Fibrin(ogen) and the pancreas 
1.6.1 Fibrin structure and function 
Fibrinogen is a soluble 340kDa protein that is 45nm in length [90]. Two D domains 
make up the outer part of the molecule that is connected by disulfide bridges to a central 
E domain. Each D domain is made up of a polypeptide trimer, named Aα, Bβ, and γ 
(Figure 1-2) [91]. Fibrinogen also contains the Arg-Gly-Asp (RGD) amino acid 
sequence, which acts as a ligand for a number of integrin receptors [92]. Fibrinogen is 
produced in the liver of rodents and humans, and circulates in the blood until activation 
by thrombin [93, 94]. The enzymatic activity of thrombin cleaves four fibrinopeptides 
from both  and  subunits, which allows the resultant fibrin monomers to 
conglomerate and polymerize [95]. Fibrin polymerization occurs because 
fibrinopeptide cleavage exposes high affinity binding sites on the α and β chains (EA 
and EB), which bind to DA and DB sites located on an adjacent fibrin monomers (Figure 
1-2) [91]. This process leads to double stranded fibrin fibrils with staggered 22.5nm 
longitudinal repeats that eventually branch via bilateral and equilateral junctions [96, 
97]. A bilateral junction occurs when two double-stranded fibrils bind adjacently to 
one, while equilateral junctions occur when three fibrin monomers interact together. 
Most frequently, the combination of both types of junctions leads to a complex mesh 
network [91, 98, 99].  
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Figure 1-2 Fibrin structure and formation.  
Fibrinogen, made by the liver, circulates in the blood stream until activation of the 
coagulation cascade, whereby thrombin eventually cleaves fibrinopeptides from 
fibrinogen. The resulting molecule is then able to polymerize and form a fibrin 
polymer by allowing binding between the D and E fragments. After exposure to factor 
XIIIa, D dimers cross-link fibrin polymer to form a fibrin network mesh. Scanning 
electron micrograph shown in bottom left to illustrate complex fibrin mesh network. 
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The native function of fibrin is to form a clot to promote wound healing. As wound 
healing occurs, the fibrin clot is slowly degraded. In this way, fibrin is a biodegradable 
provisional ECM protein [100]. High blood fibrinogen concentration has been 
associated with elevated risk of stroke and myocardial infarction [101]. However, 
overexpression of native murine fibrinogen in mice did not increase the risk of 
occlusive platelet thrombus formation [102]. But, when human fibrinogen was infused 
into mice, vessel occlusion occurred more quickly due to abnormally high fibrin content 
in the plasma [103]. These findings suggest that reducing native fibrinogen levels in 
humans could reduce the risk of thrombosis.  
Clot formation is also affected by fibrin’s structure, which can be modified by 
alternative splicing of the γ fibrinogen domain. Additionally, the concentration of 
fibrinogen and thrombin, pH, porosity, permeability and other factors have been shown 
to influence the conformation of fibrin [104-106]. Factors such as diabetes [107], 
smoking [108], and homocysteine concentration [109] also have dramatic effects on 
fibrinogen’s activity.  
1.6.2 Fibrin and integrin receptors 
Two means by which fibrin exerts its effects are by acting as a 3D scaffold emulating 
the natural extracellular environment and/or by stimulating receptors on the cell 
surface. One receptor that is stimulated by fibrin and has a well-established role in 
cancer and angiogenesis is integrin receptors αvβ3 [110, 111]. Interestingly, fibrinogen 
domains α, γ, and αEC are able to bind to integrin αvβ3 [112]. Given this, fibrin is able 
to mediate various effects on different cells. For instance, endothelial cells cultured in 
fibrin gels form lumenal structures, which depend on integrins αvβ3 and αvβ5 [113]. 
These pseudo-capillaries vary based on the relationship between integrin αvβ3 
distribution and the stretch resistance of fibrin [114]. Fibrin-integrin αvβ3 interactions 
induce morphological changes of endothelial cells, which includes enlarging the 
intracellular space [115]. In wound healing, human fibroblast expression of integrin 
αvβ3 promotes is essential for adhesion to fibrin and thus migration [116]. Integrin 
αvβ3 also mediates fibrin gel retraction during wound repair [117]. Spreading and 
migration of smooth muscle cells into fibrin gels is an important step in wound healing 
and integrin α5β1 and αvβ3 are required for this process [118]. Furthermore, the αIIbβ3 
integrin receptor, which binds fibrin, plays a role in clot formation [119]. Other cell 
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surface receptors that bind to fibrin are vascular endothelial cadherin [120], vascular 
endothelial growth factor receptor [121], integrin αMβ2 [122], and others [91]. In these 
regards, integrin αvβ3 is a key player involved in mediating the cellular effects of fibrin. 
An ECM protein related to fibrin in structure and function is fibronectin. 
1.6.3 Contrasting fibrin and fibronectin 
Fibronectin is a large glycoprotein with essential structural and functional roles. It is 
alternatively spliced such that one isoform circulates as plasma fibronectin, and the 
other isoform remains as cellular fibronectin [123]. Structurally, fibronectin contains 
domains that are able to mediate binding of other ECM proteins, as well as stimulate 
integrin receptors [123]. Like fibrin, fibronectin contains RGD domains that are a 
ligand for integrins αvβ3 and α5β1, among others [124]. This interaction causes a 
conformational change in the integrin receptor and allows outside-in signaling to occur 
[125].  
Plasma fibronectin, like fibrin, plays a role in the coagulation cascade during wound 
healing. Fibronectin and fibrin can interact during clot formation [126]. In the clot, 
plasma fibronectin’s presence increases platelet aggregation and stabilizes the 
thrombus [127]. Indeed, mice deficient for plasma fibronectin had significantly larger 
infarct size after focal cerebral ischemia and reperfusion [128]. Furthermore, in a model 
of murine atherosclerosis, loss of plasma fibronectin reduced the number of 
atherosclerotic plaques [129]. 
After these initial steps in wound healing, fibroblasts deposit cellular fibronectin, which 
allows other ECM molecules to adhere and thus regulate a variety of cellular processes 
through receptor binding [130]. This differs from fibrin because as wound repair occurs, 
fibrin is degraded and lost from the wound site. Deposition of this native fibronectin 
matrix architecture increases cell proliferation, compared to a mutant fibronectin that 
contained similar binding motifs, but an altered matrix, which inhibited cell cycle 
progression [131]. This suggests that the entire fibronectin structure, and not just 
specific binding motifs, is required for proper receptor activation. Furthermore, altered 
fibronectin matrices induced a reduction in FAK phosphorylation and p53 levels, which 
led to apoptosis induction [132]. Fibrin and fibronectin have similar functions, yet, the 
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characteristics of fibrin are such that it can easily form a 3D scaffold and will support 
long-term islet cell growth, function and angiogenesis. 
1.6.4 Fibrin use in islet cell culture and transplantation 
Fibrin is a provisional matrix protein that can support islet architecture, improve islet 
health and promote islet vascularization [133, Chapter 4]. Most importantly, islets 
embedded in 3D fibrin can be expanded in vitro without the loss of beta cell function 
that is seen with traditional culture techniques [134]. In fact, when human islets were 
cultured in fibrin, proliferation, insulin content, and GSIS increased significantly 
compared to controls (Figure 1-3) [134]. These improvements to beta cell function are 
believed to be associated with the ability of 3D fibrin to maintain cell-cell contacts and 
enable cellular response to growth factors both ex vivo and in vivo [133, Chapter 4; 
134].  
Improvements in GSIS, proliferation, and survival were observed when beta cells were 
cultured in 3D fibrin for up to 4 weeks [133, Chapter 4]. Enhancement of fibrin-cultured 
beta cell insulin secretion can also be achieved by co-culture with human umbilical vein 
endothelial cells [135]. The aforementioned study also showed that the distance 
between co-culture cell populations was critical for promoting beta cell functionality 
[135]. Fibrin also has a protective effect against apoptotic stimuli, which was 
demonstrated by subjecting fibrin-cultured young porcine islets to hydrogen peroxide 
treatment [136].  
Binding of extracellular matrix proteins, such as fibrin, to integrin receptors is critical 
for the maintenance of islet function, differentiation, and survival in vitro and in vivo 
[42, 66, 137, 138]. Our previous study demonstrated that mice with a deficiency in β1 
integrin had significantly reduced beta cell mass, proliferation, and Pdx-1 and Nkx6.1 
expression, as well as reduced signaling through the FAK/MAPK/ERK pathway [42, 
Chapter 2]. Culture of beta cells within 2D or 3D fibrin scaffolds showed islet-like 
cluster formation with significantly increased glucose-stimulated insulin secretion and 
cell proliferation, as well as decreased cell apoptosis for up to 4 weeks [133, Chapter 
4]. Fibrin improves beta cell function and survival by increasing integrin v3 protein 
levels and increasing the phosphorylation of FAK, Erk1/2 and Akt [133, Chapter 4]. 
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Taken together, fibrin binds to integrin receptors, promotes and maintains islet cluster 
formation, and improves islet health.  
Besides binding to integrin receptors, fibrin may promote in vivo islet health by 
increasing blood flow to islets via angiogenesis. Embedding islets in 3D fibrin is 
associated with significant increases in vessel cord branching from islets [139, 140]. 
Fibrin scaffolds may promote more effective angiogenesis by inducing the endothelial 
cells and endothelial progenitor cells that reside within islets to proliferate and/or 
differentiate [140]. Alternatively, the vessel changes may be in response to hypoxia 
generated from embedding islets in fibrin gels, which was demonstrated after overnight 
culture of human islets in 3D fibrin [141]. Fibrin-embedded human islets that were 
supplemented with an oxygen-diffusing medium acted synergistically to promote 
improved islet function and survival in vitro [141]. Therefore, utilization of an oxygen-
diffusing medium seems to be a simple strategy to reduce hypoxic damage to islets 
caused by islet isolation and 3D fibrin scaffolds [141]. 
1.6.5 Fibrin support of islet cell function and survival in vivo 
Fibrin has been used as a carrier for many cell types with great success [142]. With 
respect to islet transplantation, fibrin improved islet function and survival, whereby 
circulating human c-peptide levels were significantly increased in diabetic mice that 
received fibrin-cultured islets as opposed to free floating ones [134]. Indeed, the use of 
fibrin reduced the required marginal islet mass by up to 90% in a subcutaneous 
xenogeneic porcine islet transplantation model [143]. This finding could be explained 
by the observation that grafts of fibrin-embedded islets gave rise to larger islets with 
more populated endocrine cells than grafts of free-floating islet controls [134]. 
Mice that received fibrin-cultured porcine islets had highly vascularized islet structures, 
along with improved islet viability compared to controls [143]. It has been 
demonstrated that the delay in reforming vessel contacts has a significant impact on 
islet transplantation outcomes [144]. Therefore, fibrin’s pro-angiogenic effects may be 
a major factor in the observed improvements in vivo. In particular, the transplantation 
of islets to regions of poorer vascularization, such as subcutaneous sites, may benefit 
considerably from incorporation of pro-angiogenic fibrin in the graft [145]. 
Incorporation of isolated islets into extracellular matrix scaffolds for culture or 
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transplantation have also shown to be protective against intraislet endothelial cell death 
or dedifferentiation [90].  One experiment discovered that 8 days after fibrin-enriched 
human islets were subcutaneously transplanted into mice, there was a significant 
increase in islet vessel density and neovascularization [146]. If fibrin scaffolds can be 
further confirmed to provide sufficient vascularization to subcutaneously transplanted 
islet grafts, the more invasive and complicated kidney subcapsule or portal 
transplantation routes may become extinct [147]. However, before this procedure can 
enter clinical trials, future studies still need to decipher the mechanism and importance 
of donor intraislet endothelial cell versus host endothelial cell contribution to successful 
engraftment following transplantation.  
The use of fibrin also overcomes technical difficulties associated wth islet 
transplantation by allowing islets to be embedded in a fibrin carrier system that does 
not interfere with islet function or impose any short-term harm on surrounding tissues 
(Figure 1-3) [148]. Subcutaneous transplantation of fibrin-embedded islets was as 
effective as transplantation of free-floating islets under the kidney capsule in diabetic 
mice [149]. This study’s results further support the notion that fibrin is an effective 
carrier [149]. In addition, fibrin reduces islet fragmentation into lone cells that is often 
seen in free-floating transplantation procedures [145]. This observation stresses the 
utility of fibrin for islet transplantation because dispersed islets have been shown to 
undergo an integrin-mediated form of apoptosis known as anoikis [145]. Concentrating 
transplanted islet cells also ensures that these cells can generate a high enough 
concentration gradient of VEGF and other growth factors in order to promote effective 
graft angiogenesis and thus graft survival [145]. As such, fibrin is a great candidate to 
use during islet transplantation to improve transplantation outcomes. 
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Figure 1-3 Strategies for fibrin use during cell-based therapies for diabetes treatment. 
Schematic diagram for subcutaneous islet transplantation using fibrin. Isolated islets 
could be either cultured for long-term or embedded in 3D fibrin, then subcutaneously 
transplanted [134, 148]. A gross image of subcutaneously transplanted fibrin-wrapped 
human fetal pancreatic cells is shown. The dash arrow indicates the fibrin graft with 
vasculature surrounding it. 
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1.7 Rationale for thesis and objectives  
The pancreas is enriched by ECM proteins that stimulate integrin receptors to mediate 
cellular processes. However, the mechanisms behind the dynamics of integrin-ECM 
interactions in the pancreas are not clear. The overall objective of this thesis is to 
demonstrate the necessity of integrin receptors and ECM proteins in promoting both in 
vivo and in vitro proliferation, survival, function, and maturation of pancreatic cells, 
especially beta cells. The overall hypotheses in this thesis are: 1) loss of pancreatic β1 
integrin leads to glucose intolerance, with reduced proliferation and increased apoptosis 
of pancreatic beta and acinar cells and 2) culturing pancreatic cells with fibrin will 
improve beta cell function and survival, and maintain differentiation. 
The objective of Chapter 2 is to determine the in vivo role of β1 integrin in the adult 
murine endocrine pancreas using a conditional β1 integrin knockout mouse model.  
The objective of Chapter 3 is to investigate the in vivo role of β1 integrin on the adult 
exocrine pancreas using the same mouse model as Chapter 2. 
The objective of Chapter 4 is to analyze the role of fibrin-integrin interactions in support 
of beta cell function, proliferation, and survival using INS-1 cells.  
The objective of Chapter 5 is to discover the beneficial effects of fibrin-culture on 
human fetal islet-epithelial clusters and mechanisms behind these effects. 
Taken together, these studies will illustrate the requirement of integrin receptors and 
ECM to promote and maintain adult and fetal cell function, survival, proliferation, and 
maturation. Results from this work have implications for cell-based therapies for 
diabetes treatment, especially islet transplantation, as this procedure breaks the 
essential connections between cells and their native ECM environment. 
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Chapter 2  
2 Conditional β1 integrin-deficient mice display impaired 
pancreatic beta cell function2 
  
                                                 
2
 This work has been published in the following manuscript: 
 Riopel M, Krishnamurthy M, Li J, Liu S, Leask A, Wang R. Conditional β1 integrin-deficient 
mice display impaired pancreatic β cell function. J Path 2011;224(1):45-55 
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2.1 Introduction 
Integrin-ECM interactions are well known regulators of beta cell survival and function 
[1, 2]. Integrin receptors associate with ECM components, enabling cell–cell and cell–
matrix contacts and influence numerous cellular processes, including differentiation, 
proliferation and function [3 - 5]. The most extensively studied integrin in islet biology 
is β1.  Its  association with  12  α  subunits [5]  involved in  the  regulation of  
morphogenesis [6, 7], differentiation,  proliferation  [8, 9]  and  survival  [5]  has  been 
well-documented in beta cells. Integrins α3β1 and α6β1 mediate the attachment and 
spreading of rat beta cells on collagen I and 804G matrices, respectively, improving 
cell survival and insulin secretion [10, 11]. Moreover, our and other studies have 
shown that perturbing β1 integrin function in isolated islets from pre- and post-natal 
rat and human fetal pancreas caused decreased adhesion on ECM and increased islet 
cell apoptosis [1, 2, 12, 13]. Recently we also demonstrated that β1 integrin collagen I 
and IV interactions in rat insulinoma cell line, INS-1, is essential for survival, 
proliferation and insulin secretion [14], and that β1 integrin activation of the 
FAK/MAPK/ERK signalling pathway enables the differentiation and survival of 
human fetal islet cells [15]. 
We have used mice homozygous for a loxP - integrin β1 allele and hemizygous for 
tamoxifen-dependent cre recombinase expressed under the control of a collagen type I 
promoter, to test whether a conditional knockout of β1 integrin in collagen I-producing 
cells would have physiological and functional implications in pancreatic endocrine cells 
in vivo. Our results show that male β1 integrin-deficient mice demonstrate significant 
alterations in glucose tolerance and beta cell mass by 4 weeks post-tamoxifen injection 
(7 weeks of age), along with significantly reduced phospho-FAK/ERK1/2 signals and 
increased caspase-3 cleavage in the pancreas. 
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2.2 Materials and methods 
2.2.1 Conditional β1 integrin-deficient mice 
C57BL/6 mice with a tamoxifen inducible cre recombinase controlled by the col1a2 
promoter were crossed with floxed β1 integrin mice to generate conditional β1 integrin 
knockout mice in collagen I producing cells [16]. The mice used for experiments were 
genotyped by polymerase chain reaction (PCR) to detect β1 integrin and Cre as 
described previously [16]. The β1 integrin knockout was induced in 3 week old mice 
by intraperitoneal (i.p.) tamoxifen injection (4-hydroxytamoxifen; Sigma, St. Louis, 
MO, USA) [17]. Deletion of β1 integrin in the pancreas was determined by real-time 
reverse transcriptase PCR (qRT-PCR; Appendix 5), western blot (Rabbit anti-β1 
integrin, Millipore, Billerica, MA, USA) and immunofluorescence staining (Goat anti-
β1 integrin, R&D Systems, Minneapolis, MN, USA; Figure 2-1). Controls include corn 
oil-injected Cre+ mice [Cre+ Ctrl] and tamoxifen-injected Cre- mice [Cre- Ctrl]. All 
protocols were approved by the Animal User Subcommittee at the University of 
Western Ontario, in accordance with the guidelines of the Canadian Council of Animal 
Care (Appendix 1). 
2.2.2 RNA extraction and real-time RT-PCR 
Total RNA was extracted from pancreata of β1 integrin-deficient and control mice at 
1 week post-injection using the miRNeasy kit (Qiagen, Germantown, MD, USA). For 
each reverse transcription reaction, 2 mg of total RNA from whole pancreatic tissue 
were used with oligo(dT) and random primers, as well as Superscript reverse 
transcriptase (Invitrogen, Burlington, ON, CAN).  Sequences of PCR primers used for 
qRT-PCR with expected size of product are listed in Appendix 5. A master mix of 
primers, water and SYBR green was made and then added to separate tubes with each 
cDNA sample.  Real-time RT-PCR analyses were conducted using the CFX manager 
software (Bio-Rad Laboratories, Mississauga, ON, Canada) and CFX Connect Real-
Time System (Bio-Rad Laboratories). Data were normalized to levels of 18S RNA 
subunit and relative gene expression was calculated based on the 2ΔΔCT method as 
PCR signals from β1 integrin-deficient pancreata relative to control pancreata. 
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2.2.3 Immunofluorescence and morphometric analyses 
Body weight, intraperitoneal glucose (IPGTT) and insulin (IPITT) tolerance tests were 
performed in β1 integrin knockout (β1KO), Cre+ Ctrl and Cre- Ctrl mice at 4 and 7 
weeks post-injection [18]. For the IPGTT, glucose [D-(+)-glucose; dextrose; Sigma] a 
dosage of 2 mg/g of body weight was administered (i.p.) and blood glucose levels were 
examined at 0, 15, 30, 60 and 120 minutes after injection. Area under the curve (AUC) 
was used to quantify glucose responsiveness [18, 19]. For the IPITT, normal human 
insulin (Humalin, Eli Lilly, Toronto, Ontario, Canada) at 1 U/kg of body weight was 
injected [18]. GSIS tests were performed on 7 week post-tamoxifen injected male β1 
integrin-deficient mice and age-matched controls. Blood samples were collected before 
(0 minutes) and after glucose loading at 5 and 35 minutes [18]. Insulin secretion levels 
were assessed by enzyme-linked immunosorbent assay (ELISA). 
2.2.4 In vivo metabolic studies and glucose-stimulated insulin 
secretion 
Pancreatic tissues collected from β1 integrin-deficient, Cre+ and Cre− Ctrl mice at 4 
and 7 weeks post-injection were fixed in 4% paraformaldehyde. Pancreatic tissue 
sections (4 µm thick) were prepared from the entire length of the pancreas and stained 
with haematoxylin  and  eosin  (H&E),  Masson’s  trichrome  (for total collagen 
analysis), picrosirius red (for birefringent collagen I staining [20]) or with 
appropriate dilutions of primary antibodies, as listed in Appendix 4. Fluorescent 
secondary antibodies were obtained from Jackson Immunoresearch Laboratories 
(West Grove, PA, USA).  
Areas of alpha and beta cells in sections from all groups were traced manually with 
a minimum of five pancreata per age group per experimental group. Total alpha and 
beta cell mass was determined using previously described methods [21]. The 
percentage of Ki67, Pdx-1 and Nkx6.1 labelled in beta cells was determined by 
double immunostaining and counting beta cells from at least 12 islets randomly per 
pancreatic section (Appendix 4). 
To measure islet capillary area, sections were double stained with anti-mouse platelet 
endothelial cell adhesion molecule (PECAM-1) antibody and insulin (Appendix 4). 
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At least 12 islets per section were selected at random, and islet capillaries were traced 
manually. The ratio of islet capillary area to the total islet area was calculated to 
determine the proportion of vessels occupying the islet area [22]. A minimum of five 
pancreata per age group per experimental group was analysed [18]. 
2.2.5 Insulin enzyme-linked immunosorbent assay (ELISA)  
Pancreatic insulin was extracted in an ethanol – acid solution (165 mM HCl in 75% 
ethanol). Plasma and pancreatic insulin content were measured using a mouse 
ultrasensitive insulin ELISA kit (ALPCO, Salem, NH, USA) with a sensitivity of 0.15 
ng/ml, according to the manufacturer’s instructions. Insulin release and content was 
expressed as ng/ml and ng/mg protein, respectively. 
2.2.6 Protein extraction and western blot analysis 
Protein extraction and western blot analyses were conducted as previously described 
[15]. Briefly, protein from β1 integrin-deficient and Cre+ control pancreata was 
extracted in Nonidet-P40 lysis buffer. Equal amounts (35 μg) of lysate proteins from 
each experimental group was separated by either 5%, 10% or 12% sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a 
nitrocellulose membrane (Bio-Rad Laboratories). Membranes were incubated with 
appropriate dilutions of primary antibodies, as listen in Table 2 (see Appendix 4), 
followed by the application of appropriate horseradish peroxidase (HRP)-conjugated 
secondary antibodies (Santa Cruz Biotechnologies, Santa Cruz, CA, USA). Proteins 
were detected using ECL-Plus western blog detection reagents (Perkin Elmer, 
Wellesley, MA, USA) and exposed to BioMax MR Film (Kodak, Rochester, NY, 
USA), Densitometric quantification of bands at subsaturation levels was performed 
using Syngenetool gel analysis software (Syngene, Cambridge, UK) and normalized 
to appropriate loading controls. Data are expressed as the relative expression levels of 
phosphorylated proteins to total protein levels or protein levels to the loading control 
(calnexin) [15]. 
2.2.7 Statistical analysis 
Data are expressed as mean ± standard error of the mean (SE). Statistical significance 
was determined using either the unpaired Student’s t -test or one-way analysis of   
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Figure 2-1 Decreased β1 integrin expression in the pancreas of knockout mice  
(A) qRT – PCR analysis of β1-integrin mRNA (n = 5) and (B) immunofluorescence 
staining for β1 integrin in pancreata from 1 week post-injected male β1 integrin-
deficient and Cre+ control mice. (C) Western blots and quantitative analysis of β1 
protein (n = 3) in pancreata from 4 weeks post-injected male β1 integrin-deficient and 
Cre+ control mice. Data are expressed as means  SE. ∗p < 0.05, ∗∗p < 0.01 versus 
Cre+ control mice. Scale bar = 50 µm. KO, knockout; Ctrl, control
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Supplemental Figure 2-i Effect of β1 integrin deficiency on the pancreas of 4 week 
post-injected β1 integrin knockout mice.  
Body and pancreas weight of β1 integrin knockout male and female mice with 
respective controls. Data are expressed as means  SE (n=5-10). *p<0.05 vs. Cre+- 
and Cre--control mice.  
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variance (ANOVA), followed by post hoc least significant differences and Bonferroni 
comparison test. Differences were considered statistically significant when p < 0.05. 
2.3 Results 
2.3.1 Decreased β1 integrin expression observed in the 
pancreas of β1 integrin-deficient mice 
By 1 week post-tamoxifen treatment, the expression of β1 integrin mRNA in the 
pancreas of β1 integrin-deficient mice  was  significantly reduced  by 50%, determined 
by qRT – PCR (p < 0.05, Figure 2-1A), and showed decreased β1 integrin staining in 
pancreatic  exocrine  and  islet  cells  (Figure 2-1B). Total β1 integrin protein in the 
pancreas was significantly reduced after 4 weeks post-tamoxifen injection (p < 0.01, 
Figure 2-1C). 
2.3.2 β1 integrin-deficient mice showed a reduction of body and 
pancreas weight 
The body weight of male β1 integrin-deficient mice displayed significant decreases at 
4 and 7 weeks post-tamoxifen injection when compared to Cre+ and Cre− controls (p 
< 0.05, Figure 2-2A, upper panel; Supplementary Figure 2-i). However, reduced 
weight in female β1 integrin-deficient mice was only observed at 7 weeks post-
tamoxifen injection when compared to female Cre controls (p < 0.05, Figure 2-2A, 
upper panel; Supplementary Figure 2-i). A significant reduction in pancreatic weight 
was found in male β1 integrin-deficient mice 7 weeks post-tamoxifen injection when 
compared to corresponding controls (p < 0.05, Figure 2-2A, lower panel; 
Supplementary Figure 2-i).  
It was noted that the pancreas of β1 integrin-deficient mice at 7 weeks post-tamoxifen 
injection appeared edematous (Figure 2-2B, upper panel). H&E staining of pancreatic 
sections revealed highly fragmented and torn tissue, as well as islets isolated from 
surrounding exocrine cells (Figure 2-2B, lower panel). Furthermore, Masson’s 
trichrome (Figure 2-2C, upper panel) and picrosirius red (Figure 2-2C, lower panel) 
staining revealed a relative reduction in collagen fibres and connective tissue in the 
pancreas, especially around pancreatic islets (Figure 2-2C). 
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Figure 2-2 Histology and effects of β1 integrin-deficient pancreas 
Effect of β1 integrin deficiency on the pancreas of 7 week post-injected β1 integrin-
deficient mice. (A) Body and pancreas weight of β1 integrin-deficient male and female 
mice with respective controls. Data are expressed as mean ± SE (n = 4–8). ∗p < 0.05 
versus Cre+ and Cre− control mice. (B) Photographs of the male mouse pancreas 
(dotted line) before dissection (top) and haematoxylin and eosin-stained (bottom).  (C) 
Masson’s trichrome stain shows collagen fibres in blue (top) and picosirius red stain 
shows birefringent collagen I in dark red (bottom) of pancreatic sections of male β1 
integrin-deficient mice and respective controls. Representative images are shown; 
arrows indicate the islets, arrowheads indicate the basement membrane. Scale bars = 
100 µm (B); 50 µm (C). KO, knockout; Ctrl, control. 
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Supplemental Figure 2-ii 
Intra-peritoneal glucose tolerance test (IPGTT) in female (A) and male (B) β1 integrin 
knockout, Cre+ and Cre- mice at 4 weeks post-injection. Glucose responsiveness of the 
corresponding experimental groups is shown as a measurement of the area under the 
curve of the IPGTT graphs with units of (mmol/L).  Data are expressed as means  SE 
(n=6-14).  *p < 0.05 vs. Cre+- and Cre--controls. (C) Intra-peritoneal insulin tolerance 
test in β1 integrin knockout, Cre+ and Cre- control mice at 4 weeks post-injection 
showed no changes in insulin sensitivity in all experimental groups (n=6-14). 
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2.3.3 Impaired glucose tolerance and insulin secretion in β1 
integrin-deficient male mice 
To evaluate the effects of β1 integrin deficiency on glucose metabolism, 
glucose/insulin tolerance tests were examined at 4 and 7 weeks post-injection. No 
significant changes in IPGTT were observed in female β1 integrin-deficient mice, 
despite the comparably higher peak level at 30 minutes to the controls (Figure 2-3A, 
Supplementary Figure 2-iiA). However, significantly impaired glucose tolerance was 
observed in male β1 integrin-deficient mice at 4 and 7 weeks post-tamoxifen injection 
(p < 0.05, Figure 2-3B; Supplementary Figure 2-iiB). A significant increase in blood 
glucose levels at 15 (p < 0.05) and 30 (p < 0.05) minutes following intraperitoneal 
glucose load was observed in male β1 integrin-deficient mice at 4 (Supplementary 
Figure 2-iiB) and 7 (Figure 2-3B) weeks post-injection, along with significantly 
increased area under the curve (AUC) of the IPGTT (p < 0.05, Figure 2-3B; 
Supplementary Figure 2-iiB). Furthermore, insulin sensitivity, as determine via IPITT, 
was unaltered among the experimental groups at 4 and 7 weeks post-injection (Figure 
2-3C; Supplementary Figure 2-iiC). Assessment of GSIS showed less insulin secretion 
in 7 week post-injected male β1 integrin-deficient mice compared to Cre+ control 
littermates (Figure 2-3D). 
2.3.4 β1 integrin-deficient mice showed a reduction of beta cell 
mass along with reduced pancreatic insulin content 
Our results showed that male β1 integrin-deficient mice display diabetic symptoms at 
4 weeks post- tamoxifen injection. Therefore, morphometric analyses were performed 
to further examine effects of lacking β1 integrin. The number of islets in the pancreas 
revealed no difference between the genders or between the β1 integrin-deficient mice 
and their controls at 7 weeks post-injection (Figure 2-4A).  However, partitioning islets 
by size showed a significant increase in small islets (<500 µm2), with decreases in 
large (2501 – 10 000 µm2) and extra-large (>10 000 µm2) islets in male β1 integrin-
deficient mice pancreas when compared to controls at 7 weeks post-injection (Figure 
2-4B). No difference in islet size was observed in female β1 integrin-deficient mice. 
Morphometric analysis revealed no changes in alpha cell mass between the genders 
and among study groups at 4 (Supplementary Figure 2-iiiA) and 7 (Figure 2-4C) weeks   
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Figure 2-3 Metabolic studies in β1KO mice and controls 
Intraperitoneal glucose tolerance test (IPGTT) in (A) female and (B) male β1 integrin 
knockout, Cre+ and Cre− mice at 7 weeks post-injection. Glucose responsiveness of 
the corresponding experimental groups is shown as a measurement of the area under 
the curve of the IPGTT graphs with units of (mM). Data are expressed as mean ± SE 
(n = 5 – 10). ∗p < 0.05 versus Cre+ and Cre− controls. (C) Intraperitoneal insulin 
tolerance test in β1 integrin knockout, Cre+ and Cre− control mice at 7 weeks post-
injection showed no changes in insulin sensitivity in all experimental groups (n = 3 
– 12). (D) Glucose-stimulated insulin secretion of 7 week post-injected male β1 
integrin knockout and Cre+ control mice. β1 integrin-deficient mice demonstrate a 
reduction in plasma insulin release after glucose loading (n = 3 – 6). KO, knockout; 
Ctrl, control. 
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Supplemental Figure 2-iii Morphometric analysis of alpha (A) and beta cell (B) mass 
in β1 integrin knockout and Cre control mice at 4 weeks post-injection (n=3-6). 
Glucagon (C) and insulin (D) positive area over islet area in male β1 integrin knockout 
pancreas compared to controls (Cre+/Cre-) at 7 weeks post-injection (n=3-4). (E) 
Insulin positive area per pancreatic section area and (F) ratio of alpha to beta cells in 
the pancreas of male β1 integrin knockout and control mice at 7 weeks post-injection 
(n=3-7). Data are expressed as means  SE. *p < 0.05, **p < 0.01 vs. Cre+- and Cre--
controls. 
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post-injection. beta cell mass of 4 (Supplementary Figure 2-iiiB) and 7 (Figure 2-4D) 
weeks post-tamoxifen injected β1 integrin-deficient male mice showed a significant 
reduction when compared to controls (p < 0.05 for 4 weeks, p < 0.001 for 7 weeks, 
Figure 2-4D). 
To confirm that the reduction in beta cell mass was not only due to the reduction in 
pancreatic weight, we examined the ratio of beta cell area to either islet (Supplementary 
Figure 2-iiiD) or pancreatic section area (Supplementary Figure 2-iiiE) and found an 
absolute reduction of total beta cell area in male β1 integrin-deficient mice (p < 0.05 – 
0.01). Islets of 7 week post-injected β1 integrin knockout males had significant beta 
cell loss, which resulted in a relative increase in alpha cell area in islets (p < 0.05, 
Supplementary Figure 2-iiiC). Furthermore, the ratio of alpha cell area to beta cell area 
was increased significantly in β1 integrin knockout males when compared to controls 
(p < 0.05, Supplemental Figure 2-iiiF). Although female β1 integrin-deficient mice did 
not show a statistically significant glucose metabolic disorder at either 4 or 7 weeks 
post-tamoxifen injection, a significant reduction in beta cell mass at 7 weeks post-
tamoxifen injection was observed when compared to controls (p < 0.05, Figure 2-4D). 
Furthermore, pancreatic insulin content was significantly decreased in β1 integrin-
deficient male (p < 0.01) and female (p < 0.05) mice at 7 weeks post-tamoxifen 
injection when compared to controls (Figure 2-4E). 
2.3.5 Reduced beta cell proliferation, Pdx-1 and Nkx6.1 
expression in β1 integrin-deficient mice 
A significant reduction in Ki67+/insulin+-labelled cells was observed in 4 (p < 0.05; 
Supplementary Figure 2-ivA) and 7 (p < 0.05; Figure 2-5A) week post-tamoxifen 
injected male β1 integrin-deficient mice when compared to controls. Although female 
β1 integrin-deficient mice showed lower proliferative capacity than that of the controls, 
no statistical significance was observed (Figure 2-5A). Furthermore, we found that 
Pdx-1 expression, a transcription factor important in regulating insulin gene 
expression, was significantly decreased in beta cells of both male (p < 0.001) and 
female (p < 0.05) β1 integrin-deficient mice at 4 and 7 weeks post-tamoxifen injection 
when compared to their respective controls (Figure 2-5B; Supplementary Figure 2-
ivB). Moreover, a significant decrease in Nkx6.1 expression was observed in 7 week   
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Figure 2-4 Morphometric analysis of β1KO mice and controls  
Morphometric analysis of (A) islet numbers,  (B) islet size, (C) alpha cell mass and 
(D) beta cell mass in β1 integrin-deficient and Cre control mice at 7 weeks post-
injection (n = 4 – 9). (E) Insulin content in the pancreas of β1 integrin-deficient and 
Cre controls at 7 weeks post-injection (n = 5). Data are expressed as mean ± SE. ∗p 
< 0.05, ∗∗p < 0.01 ∗∗∗ p < 0.001 versus Cre+ and Cre− controls. KO, knockout; Ctrl, 
control. 
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Supplemental Figure 2-iv Quantitative analysis of Ki67 (A), Pdx-1 (B), Nkx6.1 (C) 
expression in beta cells of β1 integrin-deficient and control mice at 4 weeks post-
injection. Data are expressed as mean percent of positive cells over insulin+ cells  SE 
(n=3-8) *p < 0.05 and **p < 0.01 vs. Cre+- and Cre--controls. 
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post-tamoxifen injected male and female β1 integrin-deficient mice when compared to 
controls (p < 0.05, Figure 2-5C). 
2.3.6 Reduced islet capillary area in male β1 integrin-deficient 
mice 
To understand whether pancreatic β1 integrin deficiency had an affect on islet 
vasculature, a measurement of islet capillary area was performed in both β1 integrin-
deficient and control mice at 7 weeks post-injection. Double immunofluorescent 
staining for PECAM-1 and insulin showed less PECAM-1+ area present in islets of β1 
integrin-deficient mice (Figure 2-6A). Male β1 integrin-deficient mice demonstrated 
40% less islet capillary area per islet when compared to controls (p < 0.05, Figure 2-
6B), while β1 integrin-deficient females displayed only a slight reduction when 
compared to controls (Figure 2-6B). 
2.3.7 Reduction of phospho-FAK, phospho-ERK1/2 and cyclin 
D1 expression along with increased caspase 3 cleavage in 
β1 integrin-deficient male mice 
Our previous studies have demonstrated that β1 integrin signals primarily via the FAK 
– MAPK – ERK1/2 pathway to regulate proliferation and function in isolated beta cells 
[15]. Here, we revealed the in vivo pancreatic β1 integrin signalling cascade and found 
a 40% reduction in phospho-FAK (p < 0.05,  Figure 2-7A), with a 75% reduction of 
phospho-ERK1/2 levels (p < 0.001, Figure 2-7B) in 4 week post-tamoxifen injected 
β1 integrin- deficient male mice compared to Cre+ controls. Furthermore, an increase 
in cleaved caspase 3 (p < 0.01, Figure 2-7C) and a reduction of cyclin D1 expression 
(p < 0.001, Figure 2-7D) was detected in β1 integrin-deficient male mice, while there 
was no alteration in phospho-Akt expression in the pancreas (Figure 2-7F). Finally, 
western blot analysis showed a 50% reduction in Pdx-1 expression in β1 integrin-
deficient male pancreas when compared to controls (p < 0.05, Figure 2-7E). 
2.4 Discussion 
We have shown that β1 integrin in the pancreas is a critical regulator of beta cell 
proliferation and function in vivo. Significant reduction of β1 integrin expression in  
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Figure 2-5 Transcription factor expression in β1KO and control mice 
Quantitative analysis of (A) Ki67, (B) Pdx-1 and (C) Nkx6.1 expression in beta cells of 
β1 integrin-deficient and control mice at 7 weeks post-injection. Data are expressed as 
mean percentage of positive cells over insulin+ cells ± SE (n = 4–7) ∗p < 0.05 and ***p 
< 0.001 versus Cre+ and Cre− controls. KO, knockout; Ctrl, control. 
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the pancreas resulted in disrupted pancreatic morphology, including a reduction of 
total pancreatic weight and pancreatic collagen matrices. ECM proteins are well 
known to be essential for cell – cell interactions and promoting cell survival and 
function through integrin receptors [23]. As such, loss of β1 integrin in pancreatic 
ECM-producing cells contributed to the observed reduction in pancreas weight and 
altered pancreatic function, which may also be associated with the loss of body weight 
in β1 integrin-deficient mice. These results were in correlation with a study using mice 
with a pancreas-specific knockout of β1 integrin [24]. Furthermore, altered glucose 
metabolism in β1 integrin-deficient mice was observed, which was associated with a 
50 – 70% reduction in beta cell mass and cell proliferation, along with a significant 
decrease in pancreatic insulin content. These results indicate that β1 integrin deficiency 
is responsible for the loss of blood glucose control as well as changes in pancreatic 
morphology. 
It is well established that Pdx-1 and Nkx6.1 expression are integral to normal 
development of the pancreas and maintenance of beta cell function [25 – 27]. Reduced 
Pdx-1 and Nkx6.1 expression in β1 integrin-deficient mice suggests that not only is β1 
integrin required for normal beta cell development and function but that it may be 
involved in mediating Pdx-1 and Nkx6.1 protein expression. Mice containing only one 
functional allele of Pdx-1 (Pdx-1+/−) demonstrated increased islet cell apoptosis and 
reduced beta cell mass [28]. Thus, reduced beta cell mass and insulin content, as well 
as glucose intolerance observed in β1 integrin-deficient mice, may also be due to low 
levels of Pdx-1 and Nkx6.1 in their pancreatic islets. 
Besides transcription factor expression, islet capillary area was also significantly 
reduced in β1 integrin-deficient males. Nikolova et al have demonstrated the 
requirement for adequate islet endothelial cells for production of basement membrane 
components (primarily laminins), which stimulate β1 integrins to promote beta cell 
proliferation and insulin gene expression [29]. Also, proper vessel function is 
necessary to supply enough blood to islets for ideal glucose sensing and insulin 
response [30]. This suggests that β1 integrin loss in islets has an effect on endothelial 
cell function, which may further contribute to beta cell dysfunction by restricting blood 
flow or impairing the production of basement membrane. 
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Figure 2-6 Effect of β1 integrin knockout on islet capillary area  
(A) Immunofluorescence staining for PECAM-1 (red) of a 7 week post-injected β1 
integrin-deficient and control islet (dotted lines). (B) Morphometric analysis of islet 
capillary area at 7 week post-injected β1 knockout and control mice. Data are 
expressed as means ± SE (n = 3–6) ∗p < 0.05 versus Cre+ and Cre− controls. KO, 
knockout; Ctrl, control. Scale bar = 50 µm. 
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In several model systems, β1 integrin has been shown to activate the FAK/MAPK/ERK 
cascade to enhance cell survival and function [31, 32]. Hammer et al determined that 
804G matrix protects against rat adult beta cell apoptosis through the β1 integrin – FAK 
signalling pathway [33], while our previous in vitro studies have demonstrated that β1 
integrin signalling through the FAK/MAPK/ERK pathway regulates the differentiation 
and survival of human fetal islet cells [15]. To investigate the signalling cascade of β1 
integrin in vivo, alterations in phospho-FAK, ERK1/2 and Akt were examined, along 
with cyclin D1 expression and caspase 3 cleavage. Significant decreases in  phospho-
FAK and ERK1/2 were observed, along with reduced cyclin D1 expression and 
increased caspase 3 cleavage, but no effect on Akt pathway, indicating that β1 integrin 
signals primarily through  the FAK/MAPK/ERK cascade in vivo to regulate glucose 
metabolism and beta cell survival and function. 
Our data indicate that loss of β1 integrin affects pancreatic structure and function in 
male, but less in female, mice. The observed differences in the requirement for integrin 
β1 in glucose metabolism are consistent with previous results indicating that there are 
gender differences in glucose metabolism. Our previous characterization of cKit Wv 
mutant mice revealed severe glucose intolerance, reduced beta cell mass and low cell 
proliferation rates in insulin+ cells, primarily in male mice [18]. Moreover, oestrogen 
administration has been shown to protect mice from beta cell ablation from STZ 
administration by preventing beta cell apoptosis [34]. 
In summary, this study is the first, using a conditional β1 integrin-deficient mouse 
model, to demonstrate the physiological and functional effects of β1 integrin 
deficiency on the endocrine pancreas in vivo. β1 integrin plays an important role in 
maintaining beta cell mass, glucose metabolism, islet capillary size as well as Pdx-1 
and Nkx6.1 expression. Moreover, our data showed that β1 integrin primarily signals 
through the FAK/MAPK/ERK cascade to regulate these physiological and 
morphological parameters in vivo. This study increases our understanding of integrin 
– ECM interactions and should prove very useful for cell-based therapies for the 
treatment of diabetes. 
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Figure 2-7 Signaling pathway activity in β1KO and control mice  
Down-regulation of phospho-FAK/ERK1/2 signalling in β1 integrin-deficient mouse 
pancreata. Western blot analyses of: (A) phosphorylated and total FAK; (B) 
phosphorylated and total ERK1/2; (C) cleaved and total caspase-3; (D) cyclin D1; (E) 
Pdx-1; and (F) phosphorylated and total Akt expression in the pancreas of male β1 
integrin-deficient and control mice at 4 weeks post-injection. Representative blots are 
shown. Data are normalized to the Cre+ controls (set at 1) and expressed as mean ± SE 
(n = 3) ∗p < 0.05, ∗∗ p < 0.01 and ∗∗∗ p < 0.001 versus Cre+ controls. P, 
phosphorylated; T, total: C, cleaved; KO, knockout; Ctrl, control. 
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Chapter 3  
3 β1 integrin-extracellular matrix interactions are essential 
for maintaining exocrine pancreas architecture and 
function3  
  
                                                 
3
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3.1 Introduction 
Integrin receptors have a significant role in cell–cell and cell–ECM contacts in many 
different tissue types. There are 18 α and 8 β receptors capable of forming 24 heterodimeric 
interactions; yet, half these interactions are made up by β1 integrin receptors [1]. This β1 
integrin receptor group is largely responsible for attachment to the ECM [2]. Upon 
stimulation, β1 integrin has been shown to mediate cell motility, survival, proliferation and 
differentiation [2-5]. 
Pancreatic acini are enclosed round structures that produce digestive enzymes [6]. Basal 
lamina covers the acini at the basal surface, stimulating   acini   integrin   receptors [6]. 
Pancreatic stellate cells (PSCs) are identified as periacinar fibroblast-like cells of the 
pancreas that express glial fibrillary acidic protein (GFAP) and produce ECM proteins in 
support of surrounding tissue [7]. PSCs are also, in part, responsible for the fibrosis 
observed in chronic pancreatitis [8, 9]. Previous studies have shown that α3β1 integrin is 
essential for proper apical/basolateral cell surface receptor organization and basement 
membrane formation in the submandibular gland [10]. As well, β1 integrin deficiency has 
shown to interfere with laminin-1 expression and basement membrane synthesis and 
assembly in embryoid bodies [11] and teratoma [12], as well as collagen IV expression in 
the lens fiber of mice [13]. This is also true for proper fibronectin assembly, which requires 
α5β1 integrin [14]. β1 integrin has been studied  in many tissues, yet the  role of β1 integrin 
in the postnatal exocrine pancreas is almost wholly unknown.  One recent study examined 
the effect of loss of β1 integrin expression in acinar cells during development; 6-week-old 
β1 integrin-deficient mice were susceptible to pancreatitis and displayed aberrant acinar 
cell polarity and necrosis [15]. More recently, we have begun to probe the role of β1 integrin 
expression in the postnatal, developed pancreas, using a tamoxifen-dependent cre 
recombinase expressed under the control of a collagen I-specific promoter/enhancer.     
We demonstrated that adult mice deficient in β1 integrin showed impaired glucose 
tolerance with a significant reduction in pancreatic beta cell function, consistent with the 
onset of diabetes. Furthermore, these β1 integrin-deficient mice displayed a significant 
decrease in pancreatic FAK and ERK1/2 activation, along with increased caspase-3 
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cleavage and decreased cyclin D1 expression [16]. However, the effects of β1 integrin 
deficiency on pancreatic exocrine morphology and function in conditional β1 integrin-
deficient mice have still to be determined. 
Here, we used mice homozygous for a loxP-β1 integrin allele and hemizygous for 
tamoxifen-dependent cre recombinase expressed under the control of a collagen type I 
promoter to analyze   pancreatic   exocrine   morphology   and   function in vivo [16]. We 
found  that  mice with  β1  integrin  deficiency controlled by the collagen I promoter had a 
primary defect in PSCs and  islets in the pancreas, which lead to  a significant decrease in  
ECM products  in  the  exocrine  compartment. β1 integrin-deficient  mice  displayed 
significantly decreased food intake with a loss of body weight, which was associated with  
reduced  pancreatic amylase, carboxypeptidase A and regenerating islet-derived protein II 
expression. These β1 integrin-deficient mice also demonstrated decreased exocrine cell 
proliferation and increased apoptosis. Interestingly, cultured acinar cell clusters isolated 
from β1 integrin-deficient mouse pancreata in the presence of ECM proteins showed an 
improved acinar cell apoptosis. This study indicates that sufficient ECM and β1 integrin 
interactions are essential for maintaining exocrine pancreatic integrity and function. 
3.2 Materials and methods 
3.2.1 Conditional β1 integrin-deficient mice 
To generate conditional β1KO in collagen I-producing cells, floxed β1 integrin mice were 
crossed with C57BL/6 mice containing CRE-ERT (tamoxifen-inducible cre recombinase) 
gene downstream of the collagen type Ia2 (Col1a2) promoter, as described previously [17]. 
Progeny mice with positive genotype, as analyzed by PCR [17], were induced by 
intraperitoneal injection of 1 mg tamoxifen (4-hydroxytamoxifen; Sigma, St Louis, MO, 
USA) per mouse per day for 5 days at 3 weeks of age [16]. Corn oil-injected Cre- positive 
and tamoxifen-injected Cre-negative mouse groups were merged as controls and 
experiments were carried out on male mice at 4 and 7 weeks post-injection. Deletion of β1 
integrin was confirmed by qRT-PCR, western blot and immunofluorescence as described 
previously [16]. A Rosa26loxP-STOP-lacZ mouse (Jackson Laboratories), which does not 
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express the β-galactosidase reporter gene unless cre recombinase is expressed in the 
nucleus, was crossed with Col1a2-Cre-ERT to identify the cells within the pancreas that 
expressed cre under control of the Col1a2 promoter [17]. All protocols were approved by 
the Animal Use Subcommittee at the University of Western Ontario in accordance with the 
guidelines of the Canadian Council of Animal Care (Appendix 1). 
3.2.2 Body and pancreas weight and food intake studies 
The body and pancreas weight of β1 integrin-deficient and control mice were measured at 
4 and 7 weeks post-injection. At 4 weeks post-injection, mice from both β1 integrin-
deficient and control groups were separated individually and had their food weighed daily 
at 0900 hours and monitored their food intake for a week. Data were expressed as average 
food intake per mouse per day. 
3.2.3 Acinar cell culture experiments 
To isolate acinar cell clusters, both β1 integrin-deficient and control mouse pancreata at 3 
weeks post-injection were dissected and digested with collagenase XI (1 mg/ml; Sigma). 
Acinar cell clusters were cultured in modified RPMI 1640 media [18] with either 1% BSA 
(Sigma) or 10% FBS (Invitrogen, Burlington, ON, Canada), reported to be enriched for 
ECM proteins [19, 20], for 24 h. Cell clusters from four experimental groups (β1KO-BSA, 
Ctrl-BSA, β1KO-FBS, and Ctrl-FBS) were harvested and processed for 
immunofluorescence with at least four mouse pancreata per experimental per group used. 
3.2.4 RNA extraction and real-time RT-PCR 
Total RNA was extracted from pancreata of β1 integrin-deficient and control mice at 1 
week post-injection using the miRNeasy kit (Qiagen, Germantown, MD, USA) [16]. For 
each reverse transcription reaction, 2 mg of total RNA from whole pancreatic tissue were 
used with oligo(dT) and random primers, as well as Superscript reverse transcriptase 
(Invitrogen).  Sequences of PCR primers used for RT-PCR with expected size of product 
are listed in Appendix 5. A master mix of primers, water and SYBR green was made and 
then added to separate tubes with each cDNA sample. Real-time RT-PCR analyses were 
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conducted using the CFX manager software (Bio-Rad Laboratories, Mississauga, ON, 
Canada) and CFX Connect Real-Time System (Bio-Rad Laboratories). Data were 
normalized to levels of 18S RNA subunit and relative gene expression was calculated 
based on the 2ΔΔCT method as PCR signals from β1 integrin-deficient pancreata relative 
to controls.  
3.2.5 Protein extraction and western blot analysis 
β1 integrin-deficient and control pancreata, as well as acinar cell clusters, were sonicated 
in Nonidet-P40 lysis buffer to extract protein. Equal amounts (2mg) of lysate pancreatic 
proteins from each experimental group were separated by 10 or 20% sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane 
(Bio-Rad Laboratories, Hercules, CA, USA). Membranes were incubated with appropriate 
diluted primary antibodies listed in Appendix 4. Proteins were detected using ECL™-Plus 
Western blot detection reagents (Perkin Elmer, Wellesley, MA, USA) and exposed using 
the Versadoc Imaging System (Bio-Rad Laboratories).  Densitometric quantification of 
bands at subsaturation levels was performed using Quantity One software (Bio-Rad 
Laboratories) and normalized to appropriate loading controls. Data are expressed as 
relative expression level of protein to the loading control [16]. 
3.2.6 Serum assays for amylase and pancreatic lipase 
Serum was collected from 7 week post-injected β1 integrin-deficient and control mice. To 
measure serum amylase levels, a Phadebas Test tablet (Magle Life Sciences, Lund, SWE) 
was added to diluted serum samples, based on the manufacturer’s instructions.  Amylase 
activity was measured with a spectrophotometer and determined by comparing absorbance 
values to standard curve [21]. To examine the serum level of pancreatic lipase, serum 
samples were mixed with lipase enzyme substrate and enzyme activator as per the 
manufacturer’s instructions. Pancreatic lipase activity was measured using a 
spectrophotometer and a formula offered by Genzyme Diagnostics (Charlottetown, P.E.I., 
CAN) [22]. 
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3.2.7 Extracellular matrix protein analysis 
Pancreata from β1 integrin-deficient and control mice at 7 weeks post-injection were 
dissected and fixed in 4% paraformaldehyde. Four μm thick pancreatic tissue sections were 
prepared from the entire length of the pancreas and stained with hematoxylin and eosin, 
Masson’s trichrome (for total collagen analysis), picrosirius red (for birefringent collagen 
I staining), as described previously [16]. To quantitatively evaluate fibronectin 
concentration in the pancreas of β1 integrin-deficient and control mice, a fibronectin mouse 
sandwich ELISA kit was used (Abcam, Cambridge, MA, USA).  
3.2.8 Immunofluorescence and TUNEL assay 
Sets of pancreatic tissue sections (4 μm thick) were immunofluorescently stained with 
appropriately diluted primary antibodies listed in Appendix 4. Fluorescent secondary 
antibodies were obtained from Jackson Immunoresearch Laboratories (West Grove, PA, 
USA) and 4'-6-Diamidino-2-phenylindole (DAPI, Sigma) was used for nuclear 
counterstaining [16]. 
To assess the structural organization of focal adhesion contacts in pancreatic acinar cells, 
an Actin Cytoskeleton and Focal Adhesion Staining kit (Chemicon, Temecula, CA, USA) 
containing mouse anti-vinculin monoclonal antibody and TRITC-conjugated Phalloidin 
was used. Cell proliferation was examined using Ki67 labeling (Abcam).   
To examine the cells undergoing apoptosis, the terminal deoxynucleotidyl transferase 
mediated nick end-labeling (TUNEL) assay was performed [23]. Briefly, pancreatic 
sections were pretreated with 0.1% trypsin, then incubated with the TUNEL reaction 
mixture conjugated with fluorescein-dUTP (Roche, Montreal, QUE, CAN). Percent cell 
proliferation and apoptosis were calculated by counting Ki67 or TUNEL labeled cells in 
exocrine tissue from at least 12 randomly selected fields of view per pancreatic section 
[16].  
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3.2.9 Statistical analysis 
Data are expressed as means ± SE. Statistical significance was determined using the 
unpaired student's t-test. Differences were considered to be statistically significant when 
p<0.05.  
3.3 Results 
3.3.1 Loss of β1 integrin observed in pancreatic stellate cells and 
islets with a significant reduction in ECM expression in the 
pancreas of β1 integrin-deficient mice 
To determine the pancreatic cell types that would be directly affected by the knockout of 
β1 integrin, transgenic Rosa26loxP-STOP-lacZ mice were crossed with Col1a2-CRE(ER)T 
mice [17]. The resultant mice were injected with tamoxifen to allow expression of β-
galactosidase in cells specifically expressing cre recombinase under control of the Col1a2 
promoter. Cells within the pancreas positive for β-galactosidase were detected with an anti-
β-galactosidase antibody (Figure 3-1A). Double labeling using an antibody directed against 
GFAP, a marker of PSCs [24] revealed that the Col1a2 promoter was active in PSCs 
(Figure 3-1A). Moreover, β-galactosidase expression was also found in islets of the 
pancreas (Figure 3-1A). These results indicate that these two cell populations express cre 
recombinase under the control of the Col1a2 promoter. 
To examine the effects of β1 integrin loss in PSCs and islets on pancreas function, mice 
hemizygous for Col1a2-CRE-ERT and homozygous for loxP-β1 integrin were generated.  
The resultant mice were injected with either tamoxifen or corn oil to generate mice deleted 
or not for β1 integrin in PSCs and islets.  To assess whether β1 integrin-deficient mice 
pancreas showed altered ECM expression, quantitative RT-PCR (qRT-PCR) analysis of 
collagen type Iα1 (Col1a1), collagen type Iα2 (Col1a2), fibronectin 1 (Fn1), laminin α1 
(Lama1), laminin β1 (Lamb1) and laminin γ1 (Lamc1) mRNA was performed at 1 week 
post-injection. We found a significant decrease in the expression of Col1a2 (p<0.001), Fn1 
(p<0.05) and Lamc1 (p<0.05) mRNA in β1 integrin-deficient mice pancreata when 
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compared to controls (Figure 3-1B-G). These results indicate that β1 integrin expression in 
PSCs and islets regulates ECM gene expression.  
3.3.2 Disturbed acinar cell-cell contacts and focal contact complex 
observed in the β1 integrin-deficient mouse pancreas 
Loss of β1 integrin in pancreatic PSCs and islets resulted in decreased ECM expression; 
therefore, we set to investigate any alterations in pancreatic morphology. Based on 
hematoxylin and eosin stain, we found that pancreatic acini similarly organized between 
β1 integrin-deficient and control mice. However, the detachment of acini clusters from one 
another was observed along with very basophilic stain in the periphery of the acinus in β1 
integrin-deficient pancreata (Figure 3-2A). Masson’s trichrome (Figure 3-2B; upper panel) 
and picrosirius red (Figure 3-2B; lower panel) staining revealed a reduction in collagen 
fibers and connective tissue between the acini clusters. Furthermore, analysis of pancreatic 
fibronectin protein levels in β1 integrin-deficient mice showed a significant decrease 
compared to controls (p<0.05; Figure 3-2C). Actin cytoskeleton and focal adhesion 
staining showed more robust cytoskeletal fibers along with more pronounced and 
continuous vinculin stain in control, but not β1 integrin-deficient, mouse pancreas at 7 
weeks post-tamoxifen injection (Figure 3-2D). Likewise, there was less co-locolization of 
F-actin and vinculin suggesting fewer focal adhesions in 7 week post-tamoxifen injected 
β1 integrin-deficient mice when compared to controls (Figure 3-2D). Finally, anti-laminin 
immunofluorescence showed a dramatic loss of laminin in 7 week post-tamoxifen injected 
β1 integrin-deficient mouse pancreas whereas controls show clear laminin at cell-cell 
contacts (Figure 3-2E). 
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Figure 3-1 Confirmation of β1 integrin knockout and extracellular matrix protein 
expression  
(A) Representative immunofluorescence images of the pancreas of a transgenic 
Rosa26loxP-STOP-lacZ mouse crossed with a Col1a2-CRE-ERT mouse whereby the β-
galactosidase reporter gene is expressed only if cre recombinase is present using anti-
GFAP, anti-β-galactosidase, and anti-insulin antibodies (arrows indicate colocalization of 
GFAP and β-galactosidase, while arrowheads show no colocalization). (B) Relative mRNA 
expression (normalized to 18S subunit) of Col1a1, Col1a2, Fn1, Lama1, Lamb1, Lamc1 
of β1 integrin-deficient and control mouse pancreas at 1 week post-tamoxifen injection 
(n=3-5). Data are expressed as means  SE. *p < 0.05, ***p < 0.001 vs. controls. 
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3.3.3 Reduced β1 integrin in acinar cells, along with significantly 
reduced pancreas weight and food intake observed in β1 
integrin-deficient mice 
Although the β-galactosidase stain showed a direct effect on PSCs and islets, but not acinar 
cells in the β1 integrin-deficient mouse pancreas, reduced β1 integrin expression stain in 
the acinar cell population was observed in 1 week post-tamoxifen injected β1 integrin-
deficient mice when compared to controls, but not at 3 days (Figure 3-3AB). Protein 
expression analyses confirm these results, indicating a significant reduction in β1 integrin-
deficient mice at 7 days, but not 3, when compared to controls (p<0.05; Figure 3-3CD). 
This suggests that loss of β1 integrin expression in the acinar cells may be secondary to the 
loss of ECM proteins. Analysis of body and pancreas weight in 4 and 7 week post-
tamoxifen injected β1 integrin-deficient mice showed a significantly reduced ratio of 
pancreas to body weight at 7 weeks post-injection when compared to control mice (p<0.05; 
Figure 3-3E). As well, a significant decrease in food intake was observed in 4 week post-
tamoxifen injected β1 integrin-deficient compared to controls (p<0.001; Figure 3-3F). 
3.3.4 Significantly reduced amylase expression observed in β1 
integrin-deficient mice 
To assess the defect of β1 integrin deficiency on exocrine pancreatic products, the 
expression of amylase mRNA and protein, as well as serum amylase levels were examined. 
We found that β1 integrin-deficient mice compared to controls had significant decreases in 
amylase mRNA expression (p<0.05; Figure 3-4A), with 50% reduction of serum amylase 
level (p<0.01; Figure 4B) and total amylase protein expression in the pancreas (p<0.05; 
Figure 3-4D). Furthermore, serum pancreatic lipase activity was significantly reduced in 
β1 integrin-deficient mice, but not controls (p<0.05; Figure 3-4C). Protein expression level 
of CPA and Reg-II was also significantly decreased in β1 integrin-deficient pancreata when 
compared to controls at 7 weeks post-injection (p<0.05-0.01; Figure 3-4EF), confirming 
reduced pancreatic exocrine cell function in β1 integrin-deficient mice. 
  
 76 
 
 
 
 77 
 
Figure 3-2 Histological analysis of β1 integrin-deficient and control mice 
(A) Hematoxylin and eosin, (B) picrosirius red (upper panels), and trichrome (lower 
panels) staining of β1 integrin-deficient and control mouse pancreas at 7 weeks post-
injection. Black arrows indicate positive collagen and connective tissue stain in controls 
with fewer in β1 integrin-deficient mice. (C) Relative fibronectin concentration between 
β1 integrin-deficient and control mice at 4 and 7 weeks post-injection (n=3-4). Data are 
expressed as means  SE. *p < 0.05 vs. control. Immunofluorescence was used to 
investigate focal adhesions (D) and laminin expression (E). Focal contacts are defined by 
vinculin (green) and actin filaments by TRITC-conjugated phalloidin (red). Nuclei are 
counterstained by DAPI (blue). Boxed regions display zoom, while arrows display cell-
cell contacts in focal adhesion and laminin immunofluorescence in control but not β1 
integrin-deficient mouse pancreas. Scale bar = 100μm (A) and 50μm (B, D and E). 
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3.3.5 Reduced β1 integrin in acinar cells led to significantly 
increased cell apoptosis, which was partially rescued by 
culturing acinar cell clusters with ECM proteins 
To analyze the proliferative and apoptotic status of β1 integrin-deficient mouse pancreas, 
Ki67 immunofluorescence staining and TUNEL was conducted. The percent of Ki67+ 
proliferating acinar cells was significantly decreased β1 integrin-deficient at 7 weeks post-
tamoxifen injection when compared to control mice (p<0.05; Figure 3-5A). Furthermore, 
a significant increase in acinar cells undergoing apoptosis was observed in β1 integrin-
deficient mice (p<0.001; Figure 3-5B). 
Since the primary β1 integrin defect is in PSCs and islets, we hypothesized that the 
pancreatic exocrine dysfunction is due to problematic ECM stimulation of acini. To 
investigate this, we isolated acinar cell clusters from control and β1 integrin-deficient 
pancreata and cultured them with or without FBS that contains rich ECM proteins [19, 20]. 
β1 integrin-deficient acinar cell clusters cultured with BSA showed significantly increased 
cell apoptosis when compared to the control cell clusters (p<0.05; Figure 3-5C). However, 
the number of TUNEL-positive cells in β1 integrin-deficient acinar cell clusters was 
reduced and reached control levels when cultured with FBS medium (p<0.05; Figure 3-
5C). 
3.4 Discussion 
The present study analyzed the effects of β1 integrin deficiency on pancreatic exocrine 
tissue. Our results demonstrate that β1 integrin deficiency under control of the collagen I 
promoter directly effected PSCs and islets, and this lead to significantly reduced ECM 
protein production in the pancreas. PSCs support parenchyma by secreting ECM 
components that integrins use as ligands. Indeed, PSCs in human pancreatic acini stain 
positive for collagen I, III and IV, laminin, fibronectin, and other ECM proteins [7]. 
Furthermore, there is a necessity of α5β1 integrin in connective tissue growth factor 
stimulation of PSC collagen I synthesis [25]. It has also been reported that PSC secretion 
of growth factors and ECM components are, in part, responsible for fibrosis in chronic  
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Figure 3-3 β1 integrin expression is reduced in acinar cells 
Representative immunofluorescence images of β1 integrin-deficient and control mouse 
pancreas at 3 (A) and 7 days (B) post-tamoxifen injection using an anti-β1 integrin 
antibody. Western blot analyses of β1 integrin-deficient and control mouse β1 integrin 
expression at 3 (C) and 7 days (D) post-tamoxifen injection (n=4). (E) Pancreas to body 
weight ratio in β1 integrin-deficient and control mice at 4 and 7 weeks post-injection (n=7-
17). (F) Food intake data from 4 week post-tamoxifen injected β1 integrin-deficient mice 
with respective controls (n=7-8). Data are expressed as means  SE. *p < 0.05; ***p < 
0.001 vs. controls. Scale bar = 50μm.  
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pancreatitis [8, 9]. Our results support previous research, in that β1 integrin is required to 
maintain PSC expression of certain ECM proteins, including Col1a2, Fn1 and Lamc1.  
Our observation of reduced pancreatic ECM mRNA was concomitant with disrupted cell-
cell contacts between acini along with reduced connective tissue and collagen fibers, 
laminin immunoreactivity and acinar cell expression of β1 integrin. It is unclear precisely 
which process preceded the other, but studies have demonstrated that β1 integrin loss lead 
to improper basement membrane assembly and laminin expression in teratoma [12] and 
embryoid bodies [11], implicating β1 integrin as an essential part of ECM maintenance. It 
has also been demonstrated that ECM proteins can regulate integrin expression in human 
fibroblasts [26]. Ablation of β1 integrin by inactivating monoclonal antibody treatment 
disrupted cell-cell contacts of keratinocytes [27]. Likewise, mouse mammary gland alveoli 
deficient of β1 integrin could not attach to the basement membrane laminin substratum 
[28]. This study also showed decreased focal adhesion contacts in β1 integrin-deficient 
mammary epithelium when compared to controls [27]. Taken together, the findings of this 
study demonstrate that reduced β1 integrin in PSCs had a direct effect on ECM expression, 
which in turn, effected acinar cell β1 integrin expression, cell-cell interactions, and 
subsequently cell proliferation and death.  
β1 integrin has been well-established as upstream of the mitogen-activated protein kinase 
(MAPK) pathway, which has profound effects on cell survival and proliferation [16, 23]. 
Our previous analysis of β1 integrin-deficient mice demonstrated a significant reduction in 
FAK and ERK1/2 phosphorylation, indicating reduced MAPK signaling [16]. The present 
results corroborate these studies by demonstrating a reduction in pancreatic β1 integrin, 
along with significantly decreased proliferation and increased apoptosis. To elucidate if the 
observed effects of pancreatic exocrine dysfunction were due to β1 integrin or ECM protein 
deficiency, isolated exocrine cell clusters from β1 integrin-deficient and control mouse 
pancreas were cultured in ECM-enriched medium. Our data indicate that apoptosis was 
significantly reduced in β1 integrin-deficient cell clusters when cultured in media with 
FBS, suggesting that supplementing ECM proteins to β1 integrin-deficient cell clusters can 
improve their survival status. This strengthens our working model, whereby pancreatic  
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Figure 3-4 Exocrine protein expression in β1 integrin-deficient and control mice 
(A) qRT-PCR analysis of amylase mRNA expression in 1 week post-injected β1 integrin-
deficient and control mouse pancreas (n=3). Analysis of serum (B) and pancreatic protein 
(D) amylase and serum pancreatic lipase (C) in 7 week post-injected β1 integrin-deficient 
and control mice (n=3-10). Relative carboxypeptidase-A (D) and Reg-II (E) protein 
expression in the pancreas of 7 week post-injected β1 integrin-deficient and control mice 
pancreas (n=4). Data are expressed as means  SE. *p < 0.05, **p < 0.01 vs. controls. 
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exocrine defects associated with β1 integrin deficiency may be largely due to insufficient 
ECM proteins. 
It was noted that food intake was significantly reduced in β1 integrin-deficient at 4 weeks 
post-tamoxifen injection along with a significant decrease in body weight [16]. Many 
studies have established a positive correlation between food consumption and weight gain 
[29, 30]. Food intake is controlled by a brain-gut axis associated with multiple factors 
including pancreatic enzyme secretion [31-33]. Our data demonstrated a significant 
reduction in pancreatic lipase, amylase and CPA expression, major enzymes produced by 
the exocrine pancreas, in β1 integrin-deficient mice when compared to controls, suggesting 
that the pancreatic insufficiency occurred due to the loss ECM proteins and β1 integrin in 
the pancreas. The pancreas of β1 integrin-deficient mice became significantly underweight 
at 7 weeks post-tamoxifen injection [16], which was more drastic than the drop in body 
weight as shown by the ratio of pancreas to body weight. This ratio was significantly 
decreased in β1 integrin-deficient mice when compared to controls further indicating a 
severe pancreatic defect. Meanwhile, other research has shown that reduction in food 
intake decreases serum [32] and pancreatic [33] amylase, which may be related to lower 
insulin levels. These studies are in line with our research, whereby β1 integrin-deficient 
mice display reduced pancreatic insulin along with reduced serum amylase activity and 
pancreatic amylase protein and mRNA expression [16]. Therefore, the lack of pancreatic 
ECM proteins or β1 integrin affected pancreatic enzyme levels, which may have negatively 
affected food intake, and thus body weight. 
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Figure 3-5 Cell proliferation and death is altered in β1 integrin-deficient mice  
Quantitative analysis of cell proliferation (A) and apoptosis (B) in the exocrine pancreas 
of β1 integrin-deficient and control mice at 7 weeks post-injection. (C) Apoptosis in 
exocrine cell clusters cultured in either BSA or FBS for 24 hours. The percentage of Ki67 
or TUNEL positive cells over total number of cells counted was calculated and data are 
expressed as means  SE (n=4). *p < 0.05, ***p < 0.001 vs. controls. 
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In summary, β1 integrin-deficient mice showed significant pancreatic exocrine dysfunction 
compared to controls. The decrease in pancreas to body weight ratio, essential pancreatic 
digestive enzymes and ECM matrix expression all suggest that β1 integrin and ECM 
proteins have an important role in maintaining pancreatic function and differentiation. 
Furthermore, we observed increased cell death and reduced cell proliferation, indicating 
disturbed cell survival/apoptosis homeostasis. A recovery in apoptosis was observed after 
β1 integrin-deficient cell clusters were provided ECM proteins. Taken together, these 
results implicate β1 integrin as an essential component to maintain ECM expression along 
with exocrine pancreatic structure and function. 
  
 86 
 
3.5 References 
1. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 
2002;110(6):673-87. 
2. Brakebusch C, Fässler R. Beta 1 integrin function in vivo: adhesion, migration and 
more. Cancer Metastasis Rev 2005;24(3):403-11. 
3. Bouvard D, Brakebusch C, Gustafsson E, Aszodi, A, Bengtsson T, Berna A, et al. 
Functional consequences of integrin gene mutations in mice. Circ Res 2001;89:211-
223. 
4. Danen EH, Sonnenberg A. Integrins in regulation of tissue development and function. 
J Pathol 2003;200(4): 471-80. 
5. Juliano RL, Reddig P, Alahari S, Edin M, Howe A, Aplin A. Integrin regulation of cell 
signalling and motility. Biochem Soc Trans 2004;32(Pt3):443-446. 
6. Motta PM, Macchiarelli G, Nottola SA, Correr S. Histology of the exocrine pancreas. 
Microsc Res Tech 1997;37(5-6):384-98. 
7. Saotome T, Inoue H, Fujimiya M, Fujiyama Y, Bamba T. Morphological and 
immunocytochemical identification of periacinar fibroblast-like cells derived from 
human pancreatic acini. Pancreas 1997;14(4):373-82. 
8. Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, et al. 
Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 
1998;43(1):128-33. 
9. Haber PS, Keogh GW, Apte MV, Moran CS, Stewart NL, Crawford DH, et al. 
Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. 
Am J Pathol 1999;155(4):1087-95. 
 87 
 
10. Menko AS, Kreidberg JA, Ryan TT, Van Bockstaele I, Kukuruzinska MA. Loss of 
alpha3beta1 integrin function results in an altered differentiation program in the mouse 
submandibular gland. Dev Dyn 2001;220(4):337-49. 
11. Aumailley M, Pesch M, Tunggal L, Gaill F, Fassler R. Altered synthesis of laminin 1 
and absence of basement membrane component deposition in beta 1 integrin-deficient 
embryoid bodies. J Cell Sci 2000;113:259-68. 
12. Sasaki T, Forsberg E, Bloch W, Addicks K, Fassler R, Timpl R. Deficiency of beta 1 
integrins in teratoma interferes with basement membrane assembly and laminin-1 
expression. Exp Cell Res 1998;238(1):70-81. 
13. Samuelsson AR, Belvindrah R, Wu C, Muller U, Halfter W. Beta1-integrin signaling 
is essential for lens fiber survival. Gene Regul Syst Bio 2007;1:177-89. 
14. Danen EH, Sonneveld P, Brakebusch C, Fassler R, Sonnenberg A. The fibronectin-
binding integrins alpha5beta1 and alphavbeta3 differentially modulate RhoA-GTP 
loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis. J Cell 
Biol 2002;159(6):1071-86. 
15. Bombardelli L, Carpenter ES, Wu AP, Alston N, DelGiorno EK, Crawford HC. 
Pancreas-specific ablation of beta1 integrin induces tissue degeneration by disrupting 
acinar cell polarity. Gastroenterology 2010;138(7):2531-40. 
16. Riopel M, Krishnamurthy M, Li J, Liu SX, Leask A, Wang R. Conditional β1 integrin-
deficient mice display impaired pancreatic β-cell function. J Pathol 2011;224:45-55. 
 
17. Zheng, B, Zhang Z, Black CM, de Crombrugghe B, Denton CP. Ligand-dependent 
genetic recombination in fibroblasts: a potentially powerful technique for investigating 
gene function in fibrosis. Am J Pathol 2002;160(5):1609-17. 
18. Yuan S, Duguid WP, Agapitos D, Wyllie B, Rosenberg L. Phenotypic modulation of 
hamster acinar cells by culture in collagen matrix. Exp Cell Res 1997;237(2):247-58. 
 88 
 
19. Hayman EG, Ruoslahti E. Distribution of fetal bovine serum fibronectin and 
endogenous rat cell fibronectin in extracellular matrix. J Cell Biol 1979;83(1):255-9. 
20. Koi H, Tachi C, Tojo H, Kubota T, Aso T. Effects of Matrix Proteins and Heparin-
Binding Components in Fetal Bovine Serum upon the Proliferation of Ectoplacental 
Cone Cells in Mouse Blastocysts Cultured In Vitro. Biol Reprod 1995;52:759-770. 
21. Pierre KJ, Tung KK, Nadj H. A new enzymatic kinetic method for determination of 
alpha-amylase. Clin Chem 1976;22(7):1219. 
22. Imamura S, Misaki H. A sensitive method for assay of lipase activity by coupling with 
β-oxidation enzymes of fatty acid. In: Werner, M, editor. Selected Topics in Clinical 
Enzymology: Proceedings of the 4th International Congress of Clinical Enzymology; 
1983; Washington, D.C.; 1984. p. 73. 
23. Saleem S, Li J, Yee SP, Fellows GF, Goodyer CG, Wang R. Beta1 integrin/FAK/ERK 
signaling pathway is essential for human fetal islet cell differentiation and survival. J 
Pathol 2009;219(2):182-92. 
24. Omary MB, Lugea A, Lowe AW, Pandol SJ. The pancreatic stellate cell: a star on the 
rise in pancreatic diseases. J Clin Invest 2007;117(1):50-59. 
25. Gao R, Brigstock DR. Connective tissue growth factor (CCN2) in rat pancreatic 
stellate cell function: integrin alpha5beta1 as a novel CCN2 receptor. Gastroenterology 
2005;129(3):1019-30. 
26. Xu J, Clark RA. Extracellular matrix alters PDGF regulation of fibroblast integrins. J 
Cell Biol 1996;132(1-2):239-49. 
27. Larjava H, Peltonen J, Akiyama SK, Yamada SS, Gralnick HR, Uitto J, et al. Novel 
function for beta 1 integrins in keratinocyte cell-cell interactions. J Cell Biol 
1990;110(3):803-15. 
 89 
 
28. Naylor MJ, Li N, Cheung J, Lowe ET, Lambert E, Marlow R, et al. Ablation of beta1 
integrin in mammary epithelium reveals a key role for integrin in glandular 
morphogenesis and differentiation. J Cell Biol 2005;171(4):717-28. 
29. Selman C, Lumsden S, Bünger L, Hill WG, Speakman JR. Resting metabolic rate and 
morphology in mice (Mus musculus) selected for high and low food intake. J Exp Biol 
2001;204(Pt 4):777-84. 
30. Bachmanov AA, Reed DR, Beauchamp GK, Tordoff MG. Food intake, water intake, 
and drinking spout side preference of 28 mouse strains. Behav Genet 2002;32(6):435-
43. 
31. Konturek SJ, Konturek JW, Pawlik T, Brzozowski T. Brain-gut axis and its role in the 
control of food intake. J Physiol Pharmacol 2004;55(1Pt2):137-54. 
32. Dehghan A, Mahjoor AA, Bazyar H, Kangili K. Effects of Silymarin and Food 
Restriction on Hepatic and Pancreatic Functions in Wistar Rats. Asian J Anim Vet 
Adv 2010;5(2):136-142. 
33. Lee PC, Brooks S, Lebenthal E. Effect of fasting and refeeding on pancreatic enzymes 
and secretagogue responsiveness in rats. Am J Physiol 1982;242(3):G215-21. 
 90 
 
Chapter 4  
4 Fibrin improves beta (INS-1) cell function, proliferation 
and survival through integrin αvβ34 
  
                                                 
4
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4.1 Introduction 
Diabetes Mellitus is a debilitating disease of glycemic dysfunction with increasing 
prevalence. Islet transplantation is a viable means to cure diabetes, however, donor 
shortage is a significant limitation due to the low yearly number of available donor 
pancreata [1]. As well, the current islet transplant regimen requires two donor pancreases 
to reverse diabetes [2]. To overcome such an obstacle, researchers have looked towards 
using other types of donors [3],  generating beta cells from different cell types (either fully 
differentiated cells [4], or beta cell precursors [5]), or methods to maintain existing beta 
cell proliferation and function [6].  
Of critical importance to islets and beta cells is the maintenance of ECM-integrin 
interactions. Integrins are a group of cell adhesion receptors that have profound influences 
on beta cell survival [7], differentiation [8] and function [9]. Upon engagement by ECM 
proteins, including fibronectins, collagens, and/or laminins, integrins activate and mediate 
intracellular signaling cascades [10]. Isolated islets cultured with an RDG peptide, type IV 
collagen or laminin significantly reduced cell death [11]. As well, canine islets cultured 
with type I collagen improved GSIS and islet insulin content while increasing cell survival 
[7]. Likewise, laminins are as an essential part of the islet basement membrane that 
mediates islet β1 integrin activity [12]. Culture of facultative liver stem cells (hepatic oval 
cells) with laminin induced the expression of Pdx-1, Pax-6, insulin and glucagon, 
indicating that laminin may influence islet cell differentiation [13]. Antibody inhibition of 
β1 integrin and laminin-5 interactions led to a significant reduction in beta-cell spreading 
and GSIS when compared to controls [14]. Fibronectin contains RGD domains that are 
preferentially bound by a large group of integrins. When immortalized rat insulinoma cells 
(INS-1) were cultured on fibronectin and RGD peptides, GSIS was significantly enhanced 
compared to controls [15]. While each of these ECM proteins is a viable means to improve 
short-term islet health in vitro, they are unable to maintain this benefit for long-term, nor 
can they easily form a 3D scaffold for in vivo transplantation [16]. 
Fibrin is a provisional ECM protein essential for clotting in mammals. Originally from the 
liver, fibrinogen is cleaved to fibrin by thrombin and undergoes polymerization (reviewed 
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in [17]). This can be taken advantage of, in vitro, to form gels that are biocompatible [18], 
biodegradable [19], able to support 3D scaffolds [20] and promote angiogenesis [21]. 
Fibrin also contains RGD amino acid motifs that are essential for binding integrin receptors 
such as αvβ3 [22].  As well, fibrin can enhance adult human islet function and survival [23] 
and subcutaneous transplantation of fibrin-cultured islets in diabetic mice significantly 
enhanced glucose tolerance [24]. However, the mechanism behind fibrin’s ability to 
promote beta cell health is unclear. The current research analyzed the necessity of integrins 
involved in promoting beta cell function, proliferation and survival under fibrin culture.  
4.2 Materials and methods 
4.2.1 INS-1 cell culture and fibrin gel preparation 
One million INS-1 (832/13, a gift from Dr. Christopher Newgard, Duke University Medical 
Center, USA) cells per well were cultured in RPMI-1640 containing 10% fetal bovine 
serum (Invitrogen, Burlington, ON, CAN) [25]. A fibrinogen solution (1.8mg/ml) was 
mixed with thrombin (Sigma, St Louis, MO, USA), to initiate polymerization. This 
resultant solution was then quickly administered to wells of a 24-well plate. INS-1 cells 
plus medium were then added on top of fibrin gel for the 2D experimental group, while the 
3D fibrin-cultured group had INS-1 cells added to the fibrinogen solution pre-
polymerization. Three INS-1 cell experimental groups, tissue culture polystyrene (TCPS), 
2D fibrin and 3D fibrin, were cultured for 1, 2 and 4 weeks, then samples were collected 
for analyses.  
4.2.2 Glucose-stimulated and basal insulin secretion 
Overnight media samples were collected from duplicates of INS-1 cells from each 
experimental group for basal insulin secretion levels. Meanwhile, duplicates of INS-1 cells 
from each experimental group were incubated with RPMI1640 culture media with 1% 
bovine serum albumin containing either 2.2 mmol/l or 22 mmol/l glucose for 2 hours to 
analyze GSIS. All collected samples were analyzed by a highly sensitive rat insulin ELISA 
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(Alpco, Salem, NH, USA). A static GSIS index was calculated [26], while basal insulin 
secretion was expressed as nanogram per ml. 
4.2.3 Scanning electron microscopy 
Fibrin-cultured INS-1 cells were fixed with 2.5% glutaraldehyde at 4°C overnight, then 
dehydrated with an increasing concentration gradient of ethanol. Three-dimensional fibrin 
samples were cut with scissors to expose cells. Samples were subjected to critical point 
drying and gold coating, and then visualized by a Hitachi 3400-N Variable Pressure 
Scanning Electron Microscope. 
4.2.4 Integrin αvβ3 blockade using an immunoneutralizing antibody 
INS-1 cells were preincubated with either mouse anti-αvβ3 integrin antibody or IgG 
isotype-matched negative control (10μg/ml; Abcam, Cambridge, MA, USA) for 1 hour 
then plated on 2D fibrin gels for 24 hours. Cells were then photographed and harvested for 
analyses. 
4.2.5 RNA extraction and real-time RT-PCR 
Total RNA was extracted from 1 week fibrin-cultured INS-1 cells and controls using the 
miRNeasy kit (QAIGEN, Germantown, MD, USA). Briefly, samples were washed then 
added to a volume of QIAzol lysis reagent. After vortexing, an equal volume of ethanol 
was added, and samples were spun through the RNeasy Mini Spin Column. After a series 
of washes, RNA on the column was eluted using hot elution buffer. 
For each reverse transcription reaction, 2 μg of DNA-free RNA was used with random 
hexamers/oligo-deoxythymidine primers and Superscript reverse transcriptase 
(Invitrogen).  Sequences of PCR primers used for RT-PCR with expected product size are 
listed in Appendix 5. A master mix of primers, water and SYBR green was made and then 
added to separate tubes with each cDNA sample. Real-time RT-PCR analyses were 
conducted using the CFX manager software (Bio-Rad Laboratories, Mississauga, ON, 
Canada) and CFX Connect Real-Time System (Bio-Rad Laboratories). Data were 
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normalized to levels of 18S rRNA subunit and relative gene expression was calculated 
based on the 2ΔΔCT method as PCR signals from 2D and 3D fibrin-cultured INS-1 cells 
normalized to TCPS controls. 
4.2.6 Immunofluorescence and TUNEL assay 
INS-1 cells at the end of the culture period were collected and fixed in 4% 
paraformaldehyde overnight, then agarose embedding and wax processing was undertaken. 
The sections (4 μm thick) were prepared and stained with appropriate dilutions of primary 
antibodies listen in Appendix 4. Fluorescent secondary antibodies were obtained from 
Jackson Immunoresearch Laboratories (West Grove, PA, USA). Percent co-localization of 
Pdx-1 or Ki67 with insulin was calculated by double immunofluorescence staining, and 
then cell counting of Pdx-1 or Ki67 positivity in insulin positive cells. 
The TUNEL assay was performed to examine cells undergoing apoptosis [28]. INS-1 cell 
sections were incubated with the TUNEL reaction mixture conjugated with fluorescein- 
dUTP (Roche, Montreal, QC, Canada) and anti-insulin antibodies (Zymed). The percent 
cell apoptosis was calculated by counting TUNEL-labeled cells in insulin-positive cells. 
4.2.7 Protein extraction and western blot analysis 
Fibrin-cultured and control INS-1 cell protein was extracted in Nonidet-P40 lysis buffer. 
Equal amounts (15 μg) of lysate protein from each experimental group was separated by 
either 7.5, 10 or 12% sodium dodecyl sulfate-polyacrylamide gel electrophesis and 
transferred to a nitrocellulose membrane (Bio-Rad Laboratories, Mississauga, ON, 
Canada). Membranes were incubated with appropriate dilutions of primary antibodies 
listed in Appendix 4. The application of appropriate horseradish peroxidase-conjugated 
secondary antibodies (Santa Cruz Biotechnologies, Santa Cruz, CA, USA) then followed. 
Proteins were detected using ECL™-Plus Western blot detection reagents (Perkin Elmer, 
Wellesley, MA, USA) and exposed using the Versadoc Imaging System (Bio-Rad 
Laboratories). Densitometric quantification of bands at subsaturation levels was performed 
using Quantity One software (Bio-Rad Laboratories) and normalized to appropriate 
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loading controls. Data are expressed as the relative expression level of phosphorylated 
proteins to total protein levels or protein levels to the loading control [29]. 
4.2.8 Statistical analysis 
Data are expressed as means ± SE using at least 3 to 4 different cell passages per 
experimental group, representing n = 3-4. Statistical significance was determined using 
either the unpaired student's t-test or one-way ANOVA followed by post hoc least 
significant differences and Bonferroni comparison test. Differences were considered 
statistically significant when p<0.05. 
4.3 Results 
4.3.1 INS-1 cells form islet-like clusters and interact with fibrin when 
cultured with fibrin gels 
INS-1 cells were cultured on TCPS, 2D and 3D fibrin for periods of 1, 2, and 4 weeks. 
After 1 week, INS-1 cells began to form small clusters on 2D and in 3D fibrin gels and 
expanded significantly at 2 weeks of culture, while cells cultured on TCPS grew as a 
monolayer (Fig. 4-1A). After 4 weeks, robust islet-like clusters in fibrin-cultured INS-1 
cells were often observed (Fig. 4-1A). It was noted that both TCPS and 2D fibrin gel-
cultured INS-1 cells had more dark spots associated with the clusters compared to 3D fibrin 
after 4 week of the culture (Fig. 4-1A). 
Scanning electron microscopy revealed contacts between fibrin gels and INS-1 cells in both 
2D and 3D cultures after 1 week (Fig. 4-1B). Cells cultured in 3D fibrin were enveloped 
in fibrin fibers and showed frequent contacts between the cells and fibrin; however, cells 
on 2D fibrin were only connected to fibrin at the basal surface (Fig. 4-1B, white arrows). 
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Figure 4-1 Fibrin promoted islet-like cluster formation.  
(A) INS-1 cells cultured on TCPS, on 2D and in 3D fibrin for 1, 2 and 4 weeks. Scale bars: 
100μm (B) Scanning electron micrographs of fibrin-cultured INS-1 cells. White arrows 
indicate examples of areas of fibrin-cell contacts. Scale bars: 5μm, 2μm, 2μm for 2D fibrin, 
3μm, 1μm and 1μm for 3D fibrin.  
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4.3.2 Significantly improved insulin secretion function observed in 
INS-1 cells when cultured with fibrin 
Basal insulin secretion of INS-1 cells was significantly increased in 2D fibrin after 4 weeks 
of culture, with a relative increase in 3D fibrin culture (Fig. 4-2A). A significant increase 
in GSIS was observed in 2D and 3D fibrin-cultured cells 2 weeks (Fig. 4-2B). Furthermore, 
GSIS of 3D fibrin-cultured INS-1 cells was 4-fold higher compared of TCPS controls after 
4 weeks (Fig. 4-2B). While there was a similar effect in the 2D fibrin group, statistical 
significance was not attained when compared to TCPS culture (Fig. 4-2B). 
INS-1 cells also maintained their differentiated state when cultured in fibrin as opposed to 
TCPS controls. Real-time RT-PCR analyses of important beta cell genes indicated a 
significant increase in the Ins1 gene after 1 week of 3D-fibrin culture (Fig. 4-2C). The 
protein level of Pdx-1 was significantly higher in INS-1 cells cultured with fibrin for 4 
weeks, but not 1 week (Fig. 4-2D). This increase was associated with higher co-localization 
of Pdx-1 and Insulin in INS-1 cells cultured with fibrin at 1 and 4 weeks compared to 
controls (Fig. 4-2E).  
4.3.3 Integrin αv and β3 expression plus intracellular pathway 
signaling was significantly increased in fibrin-cultured INS-1 
cells 
Since fibrin contains RGD amino acid motifs, integrins receptors that preferentially bind 
to RGD domains such as v associated with 1, β3 and β5, as well as 1 associated with 
3, α5 and α8 were examined. Real-time RT-PCR analysis of integrin mRNA showed a 
relative increase in a number of integrin receptors in fibrin-cultured INS-1 cells after 1 
week, yet statistical significance was not reached (Fig. 4-3A). Fibrin-cultured INS-1 cells 
showed significantly higher protein levels of integrins αV and β3, at 1 and 4 weeks of 
culture when compared to TCPS controls (Fig. 4-3B). However, protein expression of 
integrin α3 and β1 was relatively unchanged (Fig. 4-3C). The increases in integrin protein 
expression in fibrin-cultured INS-1 cells was associated with a significant increase in  
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Figure 4-2 Fibrin improved INS-1 cell function and increased Pdx-1 expression.  
(A) Basal insulin secretion of INS-1 cells cultured with fibrin or on TCPS. (B) INS-1 cell 
function as measured by glucose-stimulated insulin secretion in fibrin-culture of up to 4 
weeks. (C) Relative mRNA expression of important beta cell genes in INS-1 cells cultured 
with fibrin or on TCPS for 1 week. Western blot analysis (D) and the percent of Pdx-
1/insulin positive cells labeled by double immunofluorescence stain of Pdx-1 (green) with 
insulin (red) (E) in fibrin or on TCPS cultured INS-1 cells. Magnified images for each 
corresponding image are shown in the insert.  Data are expressed at means ± SE (n=3-5). 
Representative blots are shown. Arrows indicate double positive cells and scale bar: 50μm. 
*p<0.05, **p<0.01 and ***p<0.001 vs. TCPS control. 
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phosphorylated focal adhesion kinase (FAK), extracellular-signal regulated kinase 1/2 
(Erk1/2) and Akt activity at 4 weeks compared to controls (Fig. 4-3DEF). 
4.3.4 Significantly improved cell proliferation and decreased cell 
death observed in INS-1 cells when cultured with fibrin 
INS-1 cells cultured with fibrin at 1 and 4 weeks showed a significant increase in beta cell 
proliferation as labeled by Ki67 and insulin (Fig. 4-4A). As well, cyclin D1 was 
significantly increased in fibrin-cultured INS-1 cells at 4 weeks of culture (Fig. 4-4B). 
Cleaved caspase 3 level was significantly reduced in both 2D and 3D fibrin-cultured INS-
1 cells at 1 and 4 weeks of culture (Fig. 4-4C), and this was associated with a decrease in 
the number of insulin positive cells labeled by TUNEL  (Fig. 4-4D). 
4.3.5 Blockade of integrin αvβ3 increased cell death observed in 
INS-1 cells when plated on 2D fibrin 
To understand the necessity of integrin αvβ3 and fibrin interactions for cell survival, INS-
1 cells were treated with an anti-integrin αvβ3 blocking antibody then plated on 2D fibrin. 
After 24 hours, anti-αvβ3 treated INS-1 cells displayed a decrease in spreading on the fibrin 
gel (Fig. 4-5A). Activated FAK was downregulated by about 50% (Fig. 4-5B) but there 
were no changes in Erk1/2 and Akt phosphorylation, cyclin D1 or Pdx-1 expression (data 
not shown). There was, however, a significant increase in cleaved caspase-3 compared to 
both controls (Fig. 4-5C). 
4.4 Discussion 
This study investigated how fibrin can promote beneficial effects in beta cells. Long-term 
fibrin culture of INS-1 cells led to improved insulin secretion in response glucose 
stimulation and increased Pdx-1 protein expression compared to controls. Fibrin-cultured 
INS-1 cells also showed significantly improved cell proliferation and reduced cell death. 
This was associated with increased integrin αvβ3 expression and activity of downstream 
signal transduction pathways (FAK, Erk 1/2 and Akt). Finally, blockade of integrin αvβ3 
led to significant decreases in activated FAK along with significantly increased caspase-3   
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Figure 4-3 Fibrin induced integrin αvβ3 expression.  
(A) Relative mRNA expression of integrin receptors in INS-1 cells cultured for 1 week 
with fibrin or on TCPS. Western blot analysis of integrins αv and β3 (B), α3 and β1 (C) 
and phosphorylated FAK (D), Erk1/2 (E) and Akt (F) in INS-1 cells cultured with fibrin or 
on TCPS for 1 and 4 weeks. Data are expressed at means ± SE (n=3-5). Representative 
blots are shown. *p<0.05, **p<0.01 and ***p<0.001 vs. TCPS control. p: phosphorylated; 
t: total. 
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cleavage in fibrin-cultured INS-1 cells. Fibrin culture of INS-1 cells led to significantly 
increased insulin secretion in response to glucose challenge at 2 and 4 weeks of culture. 
Our study is unique from other research that showed a significant improvement in GSIS 
after 7 days [23]. However, that study used adult human islets, and also cultured them with 
hepatocyte growth factor, which may have assisted beta cells to function optimally while 
cultured with fibrin [23]. Another study cultured human pancreatic islets in 3D gels 
supplemented or not with ECM components for 10 days and observed improvements to 
islet gene expression [30]. Furthermore, when INS-1 cells were cultured with fibronectin 
or RGD peptides for 7 days, there was an improvement in cell growth and GSIS [15]. We 
did not observe significant changes in INS-1 cell function after one week culture on either 
2D or 3D when compared to TCPS culture, but phospho-FAK and ERK signaling 
molecules were slightly increased. These results suggest that: (i) fibrin may not directly 
influence beta cells, but rather maintains their functional status during long-term culture 
better than TCPS culture and/or (ii) INS-1 cells cultured on TCPS do not require ECM 
support for short-term culture due to its cancer cell phenotype. We also observed that 2D 
fibrin-cultured INS-1 cells had significantly higher basal insulin secretion, as opposed to 
GSIS, in which INS-1 cells cultured in 3D fibrin had the greatest increase. A major 
difference between 2D and 3D cultured cells is their morphology and polarization. Cells 
grown in 2D are flat, proliferate into a monolayer and are forced into an apical-basal 
polarity, while 3D-cultured cells form stellate-like clusters [31]. These changes in cell 
shape and polarity are able to modulate cellular activity, including protein synthesis and 
function [32]. There have also been reports that a 3D ECM environment can sequester and 
limit the transport of soluble factors [33]. In this manner, it is possible that under basal 
conditions, insulin is either held within fibrin, or that the 3D cell morphology is not 
conducive to insulin release without stimuli. However, under high glucose conditions, 3D 
fibrin-cultured INS-1 cells are able to overcome the barrier associated with fibrin and 
release insulin in a significant manner. 
In the short-term, we observed increases in integrin expression with slight increased 
phospho-FAK and ERK1/2; however, significant differences in signaling pathway 
activation were detected during long-term 4 week culture.  This lag may be due to the   
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Figure 4-4 Fibrin improved cell proliferation and survival  
The percent of Ki67/insulin positive cells determined by double immunofluorescence 
staining for Ki67 (green) and insulin (red) (A), western blot analysis of cyclin D1 (B) and 
cleaved caspase-3 (C) in INS-1 cells cultured with fibrin or on TCPS for 1 and 4 weeks. 
(D) The percent of beta cell death labeled by TUNEL (green) with insulin (red) staining in 
INS-1 cells cultured with fibrin or on TCPS for 1 week. Arrows indicate proliferating beta 
cells, scale bar: 50μm. Data are expressed at means ± SE (n=3-4). Representative blots are 
shown. *p<0.05, **p<0.01 and ***p<0.001 vs. TCPS control. 
 
  
 103 
 
intricate nature of integrins, which have their activation dictated by the talin protein [34]. 
As well, there could be a threshold of integrin receptors required before a substantial signal 
can be transduced to downstream protein kinases, which we observed after long-term fibrin 
culture. Finally, it is also possible that after 4 weeks of culture, maintenance of integrin 
receptor expression is greatly dimished in TCPS-cultured INS-1 cells. This may have been 
prevented in fibrin culture, which allowed cells to thrive functionally and maintain 
expression of Pdx-1, cyclin D1 and phosphorylated signaling members.  
In our study, improvements in beta cell function were associated with increased integrin 
expression, signaling pathway activity, cell proliferation and reduced cell death after 4 
weeks of culture. INS-1 cells cultured on TCPS form a monolayer after 4 weeks, as 
opposed to fibrin, which stimulates an islet-like clustering. This clustering itself may have 
been a factor that enhanced function [35]. One group has reported successful islet culture 
for up to 6 months in a specialized 3D suspension serum-free media [36] and demonstrated 
reversal of diabetes when post-cultured islets were transplanted into streptozotocin-treated 
mice [37]. These cultures are without ECM supplementation and it is unknown how this 
media functions to improve islet cell viability; however, culture in 3D suspension has been 
demonstrated to improved islet viability [38]. Integrin receptors besides αvβ3 may have 
been involved, as well as other receptors that have been shown to bind fibrin, yet not been 
characterized in beta cells such as CD44 [39]. The complete mechanism of action of 
fibrin’s effects on INS-1 cells is still unknown, since blocking integrin αvβ3 immediately 
showed a change in cleaved caspase-3. This suggests that changes in INS-1 cell function 
and proliferation are due to long-term stimulation of integrin αvβ3 or mediated by other 
cell receptors. 
The up-regulation of integrin receptors was associated with significantly increased 
phosphorylated FAK and Erk/2, which can activate the insulin promoter, as well as 
important beta cell transcription factors like Pdx-1, Beta2 or MafA [40, 41]. INS-1 cells 
cultured with 2D and 3D fibrin showed increased Pdx-1 expression, suggesting that it 
might be due to active Erk1/2 modulation. Akt was also increased in fibrin-cultured INS-1 
cells. The PI3K/Akt pathway has been shown to activate Pdx-1, promote beta cell survival,  
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Figure 4-5 Integrin αvβ3 blockade led to increased cell death when INS-1 cells were 
cultured on 2D fibrin.  
(A) Brightfield microscope images and (B) western blot analysis of focal adhesion kinase 
activity and caspase-3 cleavage in INS-1 cells treated with or without an anti-αvβ3 
blocking antibody for 24 hours. Scale bar: 100μm. Data are expressed at means ± SE (n=4). 
Representative blots are shown. *p<0.05 and ***p<0.001 vs. untreated control. 
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and increase proliferation by increasing cyclin D1 expression [42-44]. Fibrin culture of 
INS-1 cells led to up-regulation of certain integrins, namely αvβ3. Fibrin contains RGD 
domains, which can be bound by integrin αvβ3 [45] and this ECM-mediated integrin 
regulation has previously been shown in vascular smooth muscle cells [46]. Scanning 
electron microscopy revealed clear contacts between INS-1 cells and fibrin fiber 
projections (Fig. 4-1B), suggesting that cell adhesion receptors including intgerins are 
stimulated. We sought to block αvβ3 integrin-ECM interactions, in hopes of determining 
a mechanism behind fibrin-mediated improvements to beta cell function, proliferation and 
survival. In αvβ3 integrin-blocked cells, there was a significant reduction in phospho-FAK 
expression, suggesting that FAK signaling pathways are mediated by integrin αvβ3; 
however, there were no changes in Erk1/2 and Akt activation. The reasons for this could 
be that the blockade was not long enough to affect these pathways in a significant way. 
Also, other integrins could be compensating for reduced αvβ3 activity by maintaining 
Erk1/2 and Akt activity through a different means such as integrin-linked kinase, observed 
in cardiomyocytes and mammary epithelial cells [47, 48]. Cleaved caspase-3 was 
significantly increased in integrin αvβ3-blocked INS-1 cells, suggesting that interactions 
between integrin αvβ3 and fibrin may have a primary role in maintaining INS-1 survival 
via FAK signaling pathways. The other signaling pathway members that contribute to beta 
cell health via fibrin-integrin interactions remain to be investigated.  
Previous work has shown that blockade of a more promiscuous integrin, β1, led to a 
significant decrease in human fetal pancreatic cell phospho-FAK, phospho-Erk1/2 with 
increased cleaved caspases 9 and 3 [49]. Likewise, blocking β1 integrin receptors on INS-
1 cells during collagen culture reduced cell adhesion as well as Pdx-1 and insulin 
expression [25]. β1 integrin can pair with various α integrin subunits, which makes it much 
more detrimental to cells when blocked. When αvβ3 integrin was blocked in endothelial 
cells and fibroblasts, there were inhibitions in VEGF signaling and cell motility [50]. The 
role of αvβ3 integrin in angiogenesis has been well-characterized [51]; yet, in the context 
of other integrins, there is complex cross-talk between integrins that influences how cells 
will behave [52]. This cross-talk may be an important factor to consider with respect to the 
effects of fibrin-cultured beta cells. 
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4.5 Conclusions 
Fibrin is a provisional ECM protein that improves beta cell function, proliferation and 
survival. Fibrin also increases integrin expression, which may be the mechanism behind 
the beneficial effects we observed in beta cells. At least one integrin receptor, αvβ3, plays 
a role in mediating beta cell survival when cells are cultured on fibrin. Understanding how 
fibrin promotes beta cell health is essential to improve upon therapies for diabetes 
treatment. Treatments such as islet transplantation are only effective if there is a sufficient 
supply of beta cells and this supply can be increased if beta cell integrin-ECM interactions 
are understood. 
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Chapter 5  
5 Fibrin enhances human fetal islet-epithelial cell 
differentiation via p70s6k and promotes vascular 
formation during transplantation5 
  
                                                 
5
 This work has been submitted for peer-review as the following manuscript: 
Riopel M, Li J, Trinder M, Fellows G, Wang R. Fibrin enhances human fetal islet-epithelial cell 
differentiation via p70s6k and promotes vascular formation during transplantation. Biomater 
(MS#jbmt27573) 
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5.1 Introduction 
Islet transplantation for the treatment of diabetes is currently limited by a shortage of 
available donor pancreata [1]. In order to surpass this problem, generating beta cells from 
progenitor cell sources is a viable option [2]. However, this procedure and others like it 
produce low numbers of effective, functional beta cells [2]. A greater understanding of the 
factors, especially those in the microenvironment, which regulate pancreatic development 
and islet cell differentiation are required to significantly increase the yield of beta cells that 
these procedures generate for islet transplantation.  
Human pancreatic development begins at day 26 post-conception, with tubular structures 
protruding from the ventral and dorsal side of the foregut endoderm. Two transcription 
factors that are required for the initiation of pancreatic development are PTF-1A and PDX-
1 [3], in which the latter also promotes beta cell maturation and function [4]. By 8 weeks 
of age, Sry-related HMG box 9 (SOX9) is expressed in the pool of pancreatic progenitors 
[5] and is essential to support their proliferation and survival as well as maintain a 
transcriptional network with other factors [6]. SOX9 is also an important regulator of 
pancreatic endocrine cell differentiation [5]. Insulin positivity emerges around 7.5 weeks 
post-conception, followed by glucagon and somatostatin one week later [7]. Islet-like 
structures eventually form where cells commonly express more than one hormone [7]. 
Subsequently, clustering occurs leading to construction of the islet of Langerhans [8, 9].  
Cell receptors in the human fetal pancreas that promote interactions with the ECM are 
integrins. Integrins are a family of highly expressed heterodimeric alpha and beta receptors 
that bind to motifs of laminin, collagen, fibronectin and other cell surface receptors [10]. 
Integrins modulate multiple cellular processes in a variety of tissues. In the mouse 
pancreas, the conditional removal of β1 integrin leads to dysfunction of the endocrine [11] 
and exocrine [12] compartments. Removal of β1 integrin in developing pancreatic beta 
cells leads to a massive reduction in insulin positive cells and cell cycle progression genes, 
suggesting that beta cell expansion relies upon β1 integrin and ECM interactions [13]. 
Meanwhile, studies with human fetal pancreas indicate that integrins α3, α5 α6 and their 
associated β1 counterpart are present by 8 weeks of age, and increase as development 
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continues [14, 15]. Also, integrins αv with β1, β3 and β5 are important for human fetal beta 
cell adhesion and motility [16-18]. Knockdown of integrin receptors in human fetal 
pancreatic cells show that β1 integrin is required for maintenance of insulin expression, 
cell survival and adhesion [14, 18]. Likewise, loss of α3 integrin function leads to decreased 
intracellular signaling, adhesion to ECM proteins and insulin expression in human fetal 
pancreatic cells [19]. In this way, integrin receptors are important components of the human 
fetal pancreas, especially in regards to insulin expression and islet development. 
Fibrin is a protein found in blood clots. Derived from fibrinogen following activation of 
the coagulation cascade and cleavage by thrombin, fibrin forms crosslinks to form a clot 
[20]. Fibrin also contains the amino acid motif RGD, a ligand to a large group of integrin 
receptors [21]. Addition of an RGD peptide to culture has been shown to significantly 
reduce islet cell death [22]. Culture of the adult rat insulinoma cell line, INS-1, with RGD 
peptides, fibronectin and fibrin gels lead to significant improvements in glucose-stimulated 
insulin secretion and proliferation [23, 24]. Blockade of αvβ3 integrin by a neutralizing 
antibody resulted a significantly increased beta-cell apoptosis, indicating that functional 
αvβ3 integrin is required for beta-cell survival [24].  Furthermore, 3D fibrin culture of 
isolated human islets significantly enhanced beta cell function and survival [25]. Fibrin is 
able to support a 3D cellular environment [26] and promote angiogenesis [27], which may 
be beneficial for human fetal pancreatic islet cell growth and maturity during culture and/or 
transplantation [7]. 
Transplantation of human fetal pancreata has been suggested as a treatment alternative for 
diabetes due to its reduced immunogenic nature [28]. Indeed, transplantation of human 
fetal pancreatic cells into athymic diabetic mice leads to normo-glycemia [29] and the use 
of fibrin may assist in graft survival and function [25, 30]. Therefore, the objective of this 
study is to analyze whether fibrin can promote human fetal pancreas differentiation and 
proliferation in vitro and in vivo as well as the potential mechanisms involved. We 
hypothesize that fibrin will promote differentiation of human fetal pancreatic progenitor 
cells into insulin producing cells through integrin αvβ3 receptor up-regulation, 
angiogenesis stimulation and promotion of cell proliferation.  
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5.2 Materials and methods 
5.2.1 Human fetal islet-epithelial cell culture and fibrin gel 
preparation 
Human fetal pancreata (15-21 weeks of age) were collected according to protocols 
approved by the Health Sciences Research Ethics Board at Western University in 
accordance with guidelines of the Canadian Council on Health Sciences Research 
Involving Human Subjects. After dissociation by collagenase V, islet-epithelial cell 
clusters were cultured in CMRL media containing 10% fetal bovine serum (Invitrogen, 
Burlington, Ontario, CAN). To initiate polymerization, thrombin (Sigma, St Louis, MO, 
USA) was added to fibrinogen, as previously described [24]. The resultant solution was 
quickly inserted into wells of a 24-well plate to form 0.1-0.2mm thickness gel. Human fetal 
islet-epithelial cell clusters plus medium were then added on top of the fibrin gels for the 
2D experimental group or TCPS for the control group. The 3D fibrin-cultured group had 
human fetal islet-epithelial cell clusters added to the fibrinogen solution before 
polymerization to form 0.3mm 3D scaffold. Cell clusters plated on TCPS, 2D fibrin or 3D 
fibrin were cultured for 1 and 2 weeks, and then collected for analyses. For the mTOR 
inhibition study, dissociated human fetal pancreatic cells were pretreated with 20ng/mL of 
rapamycin (LC Laboratories, Woburn, MA, U.S.A.) for 30 min then plated on 2D fibrin 
for 48 hours. Samples were collected for protein and double immunofluorescence analysis. 
5.2.2 RNA extraction and real-time RT-PCR 
Total RNA was extracted from 1 week fibrin-cultured human fetal islet-epithelial cell 
clusters and controls using the miRNeasy kit (QAIGEN, Germantown, MD, USA). For 
each reverse transcription reaction, 2 μg of DNA-free RNA was used with random 
hexamers/oligo-deoxythymidine primers and superscript reverse transcriptase 
(Invitrogen).  Sequences of PCR primers used for RT-PCR with expected product size are 
listed in Appendix 5. A master mix of primers, water and SYBR green was made and then 
added to separate tubes with each cDNA sample. Real-time RT-PCR analyses were 
conducted using the CFX manager software (Bio-Rad Laboratories, Mississauga, ON, 
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Canada) and CFX Connect Real-Time System (Bio-Rad Laboratories). Data were 
normalized to levels of 18S rRNA subunit and relative gene expression was calculated 
based on the 2ΔΔCT method as PCR signals from 2D and 3D fibrin-cultured human fetal 
islet-epithelial cell clusters relative normalized to TCPS controls. 
5.2.3 Scanning electron, transmission electron and 
immunofluorescence microscopy 
For SEM, human fetal pancreata or fibrin-cultured human fetal islet-epithelial cell clusters 
were fixed with 2.5% glutaraldehyde at 4°C overnight, then dehydrated with an increasing 
concentration gradient of ethanol. Samples were subjected to critical point drying and gold 
coating, and then visualized by a Hitachi 3400-N Variable Pressure Scanning Electron 
Microscope. 
For transmission electron microscopy (TEM), human fetal pancreata were dissected, cut 
into small pieces, then fixed in 2.5% glutaraldehyde in 0.1M phosphate buffer. Post-
fixation was done with 1% osmium tetroxide. After dehydration through a graded ethanol 
series and propylene oxide treatment, samples were embedded in araldite medium and 
cured at 65°C overnight. Ultra-thin sections were cut at 60nm and examined with a Philips 
410 electron microscope (Philips Electron Optics, Hillsboro, OR, USA) at 60kV. 
For immunofluorescence microscopy, human fetal pancreata and cultured human fetal 
islet-epithelial cell clusters were collected and fixed in 4% paraformaldehyde overnight, 
followed by agarose embedding and wax processing. Sections (4μm thick) were prepared 
and stained with appropriate dilutions of primary antibodies listed in Appendix 4. 
Fluorescent secondary antibodies were obtained from Jackson Immunoresearch 
Laboratories (West Grove, PA, USA). 
5.2.4 Protein extraction and western blot analysis 
Fibrin-cultured and control cell protein was extracted in a Nonidet-P40 lysis buffer. Equal 
amounts (15μg) of lysate protein from each experimental group was separated by either 
7.5, 10 or 12% sodium dodecyl sulfate-polyacrylamide gel electrophesis and transferred to 
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a nitrocellulose membrane (Bio-Rad Laboratories, Mississauga, ON, Canada). Membranes 
were incubated with appropriate dilutions of primary antibodies listed in Appendix 4. The 
application of appropriate horseradish peroxidase-conjugated secondary antibodies (Santa 
Cruz Biotechnologies) then followed. Proteins were detected using ECL™-Plus Western 
blot detection reagents (Perkin Elmer, Wellesley, MA, USA) and exposed using the 
Versadoc Imaging System (Bio-Rad Laboratories). Densitometric quantification of bands 
at subsaturation levels was performed using Quantity One software (Bio-Rad Laboratories) 
and normalized to appropriate loading controls. Data are expressed as the relative 
expression level of phosphorylated proteins to total protein levels or protein levels to the 
loading control [11]. 
5.2.5 Transplantation of cultured human fetal islet-epithelial cell 
clusters 
Freshly isolated human fetal islet-epithelial cell clusters either mixed with fibrin or type I 
rat tail collagen were injected subcutaneously. Alternatively, cell clusters cultured for 1 
week in either 3D fibrin or 3D type I rat tail collagen were used for subcutaneously 
transplantation. Briefly, 8 week-old male nude mice were anesthetized with isoflurane and 
either empty gels or gels containing cultured human fetal islet-epithelial cell clusters were 
implanted subcutaneously. Mice were sacrificed at 1 week post-transplantation, where 
grafts were harvested for histological analyses. 
5.2.6 Statistical analysis 
Data are expressed as means ± SE using 4-5 different pancreata preparations per 
experimental group, representing n = 4-5. Statistical significance was determined using 
either the unpaired student's t-test or one-way ANOVA followed by post hoc Bonferroni 
comparison test. Differences were considered statistically significant when p<0.05. 
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5.3 Results 
5.3.1 The native human fetal pancreas contained robust 
extracellular matrix and integrin αvβ3 expression 
Human fetal pancreas at 16 weeks of age, analyzed by SEM, revealed very prominent ECM 
fibers (Fig. 5-1A). These fibers surround cell clusters, and are also present in between 
individual cells (Fig. 5-1A). Under the TEM, ECM fibers were often perpendicular to the 
cell membrane (Fig. 5-1B). The RGD-domain containing ECM protein fibronectin, was 
frequently associated with insulin positive cells (Fig. 5-1C), as determined by double 
immunofluorescence staining.  
Due to the profound expression of fibronectin in the fetal pancreas, we investigated the 
expression of one of its receptors, integrin αvβ3. Integrin αvβ3 was highly expressed in the 
developing human pancreas, and co-localized with PDX-1, insulin and CK-19 (Fig. 5-
1DEF). These findings suggest that the interactions between the ECM microenvironment 
and pancreatic integrin receptors is essential for normal human fetal islet development. 
5.3.2 Fibrin enhanced PDX-1 and VEGF-A expression while 
promoting endocrine cell differentiation of human fetal islet-
epithelial cell clusters 
Human fetal islet-epithelial cell clusters were cultured in 2D or 3D fibrin and TCPS for up 
to 2 weeks. Smaller clusters were maintained in fibrin cultured cells when compared to 
TCPS cultured group (Fig. 5-2A). Scanning electron microscopy revealed connections 
between cells and fibrin gels in both 2D and 3D cultures (Fig. 5-2B). Quantitative RT-PCR 
analysis of human fetal islet-epithelial cell clusters after 1 week of fibrin culture showed 
significantly higher expression of PDX-1, INS and GCG in 3D culture (Fig. 5-2C). Protein 
levels of PDX-1 in 2D and 3D fibrin-cultured human fetal islet-epithelial cell clusters were 
significantly increased during the culture period compared to TCPS controls (Fig. 5-2D). 
Fibrin-cultured human fetal islet-epithelial cell clusters also showed significantly higher 
expression of VEGF-A at 2 weeks of culture (Fig. 5-2E). Double immunofluorescence  
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Figure 5-1 The human fetal pancreas contains ECM fibers and expresses integrin αvβ3.  
(A) Scanning electron micrographs of human fetal pancreas at 16 weeks of age. Scale bar: 
50μm (left) and 10μm (middle). (B) Human fetal pancreas under the transmission electron 
microscope at 16 weeks of age. Scale bar: 1μm. Double immunofluorescence staining of 
human fetal pancreas at 16 weeks of age for fibronectin (green)/ insulin (red) (C) and 
integrin αvβ3 (green) with PDX-1 (red) (D), insulin (red) (E) and CK19 (red) (F). Scale 
bar: 50μm and nuclei are stained with DAPI (blue). ECM: extracellular matrix; Endo: 
endocrine cell. 
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staining revealed scattered clusters of insulin and glucagon positive cells in all culture 
conditions with a slight increase in both 2D and 3D fibrin-cultured groups relative to TCPS 
controls (Fig. 5-2F top). The majority of cells in all cultured groups were SOX9 and CK19 
positive (Fig. 5-2F middle). Higher VEGF-A expression in fibrin-cultured human fetal 
islet-epithelial cell clusters was associated with prominent CD31 positive cells and 
maintenance of Ki67 positive cells compared to the TCPS controls (Fig. 5-2F lower).  
5.3.3 Fibrin increased integrin αv and β3 expression in human fetal-
islet-epithelial cell clusters 
To investigate the mechanism behind fibrin’s enhancement of islet differentiation, we 
analyzed the expression of various integrin receptors. At the mRNA level, 1 week cultured 
human fetal islet-epithelial cell clusters had significantly increased αv and β3 integrin 
expression (Fig. 5-3A). We further confirmed this observation by western blot and found 
that the protein level of integrins αv and β3 were significantly higher in human fetal islet-
epithelial cell clusters cultured with fibrin (Fig. 5-3BC). Expression of the most prominent 
integrin, β1, was unchanged by fibrin culture (Fig. 5-3B) 
5.3.4 Fibrin induced PDX-1 expression via increased phospho-focal 
adhesion kinase and p70s6k activity in human fetal islet-
epithelial cell clusters 
Downstream of integrin receptors, phosphorylated focal adhesion kinase (FAK) was 
significantly up-regulated in human fetal islet-epithelial cell clusters during 2D and 3D 
fibrin culture compared to controls (Fig. 5-4A). No changes were observed in pathways 
further downstream the FAK pathway, including phosphorylated AKT (Fig. 5-4B) and 
activated ERK1/2 (Fig. 5-4C). However, phosphorylated p70s6k, a member of the mTOR 
pathway, revealed significant up-regulation in human fetal pancreatic cells cultured with 
fibrin compared to controls (Fig. 5-4D). 
Using the mTOR pathway inhibitor, rapamycin, to treat human fetal islet-epithelial cell 
clusters cultured on 2D fibrin, a significant decrease in phosphorylated p70s6k was observed   
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Figure 5-2 Fibrin improves human fetal pancreatic cell differentiation and increases VEGF-
A expression.  
(A) Human fetal pancreatic cells cultured on tissue-culture polystyrene (TCPS), on 2D and 
in 3D fibrin for 3 days. Scale bars: 100μm. (B) Scanning electron micrograms of fibrin-
cultured human fetal pancreatic cells. Scale bars: 20μm. (C) Real time RT-PCR analysis 
of PDX-1, insulin and glucagon mRNA expression in human fetal pancreatic cells cultured 
for 1 week with fibrin or on TCPS. Western blot analysis of PDX-1 (D) and VEGF-A (E) 
in human fetal pancreatic cells during 1 and 2 weeks of fibrin culture. (F) Representative 
immunofluorescence images of human fetal pancreatic cells cultured with fibrin being 
stained for insulin (red)/ glucagon (green) (top row), SOX9 (red)/ CK19 (green) (middle 
row) and CD31 (red) / Ki67 (green) (bottom row) and the percentage of the positive cells. 
Nuclei are stained with DAPI in blue. Scale bars: 50μm. Data are expressed as means ± SE 
(n=3-5). Representative blots are shown. *p<0.05, **p<0.01 and ***p<0.001 vs. TCPS 
control. 
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(Fig. 5-4E). Two dimentional fibrin cultures were used because the cells were affected to 
the same extent as 3D fibrin culture with respect to PDX-1 protein expression and signaling 
pathway activity. Inhibition of the mTOR pathway resulted in a significant decrease in 
PDX-1 expression, observed by western blot (Fig. 5-4F). Furthermore, the effects of 
rapamycin treatment on fibrin-cultured human fetal islet-epithelial cell clusters caused a 
reduction in cell proliferation, noted by cyclin D1 expression and Ki67 
immunofluorescence (Fig. 5-4GH). 
5.3.5 Subcutaneous injection of human fetal islet-epithelial cell 
clusters with fibrin improved vascularization 
To investigate how fibrin could be used as a vehicle to transplant cells subcutaneously, 
male nude mice were injected with freshly isolated human islet-epithelial cell clusters cells 
mixed with fibrin immediately before polymerization (Fig. 5-5A). Cells mixed with 
collagen I (Fig. 5-5B), empty fibrin and empty type I collagen (Fig. 5-5C) were used as 
controls. A fibrin-wrapped cell graft was clearly observed under the skin of the nude mice 
(Fig. 5-5A left). A cell core was clear, with the presence of vasculature around the fibrin-
wrapped graft interface (Fig. 5-5A right). A collagen-wrapped cell graft was also present 
under the skin of nude mice; however, prominent vascular development was not observed 
(Fig. 5-5B). At the cellular level, fibrin- and collagen I-wrapped human fetal islet-epithelial 
cell grafts after 1 week implantation in vivo had relatively similar levels of insulin and 
glucagon positivity (Fig. 5-5D 1st row). Both fibrin- and collagen I-wrapped human fetal 
islet-epithelial cell grafts showed higher a number of SOX9/CK19 positive cells compared 
to pre-implantation samples (Fig. 5-5D 2nd row). An antibody raised against human 
mitochondrial surface (HMS) protein allowed for identification of the implanted human 
fetal cells. These HMS positive cells showed a high level of cell proliferation as marked 
by Ki67 in both the fibrin- and collagen-wrapped groups (Fig. 5-5D 3rd row). Implanted 
human cells in the fibrin-wrapped group contained a high number of CD31 positive cells 
with visible host CD31 positive cells around the graft (Fig. 5-5D 4th row). The collagen-
wrapped group had large HMS-positive vessels with minimal small vessels (Fig. 5-5D 4th 
row).  
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Figure 5-3 Fibrin induces integrin αvβ3 expression in human fetal pancreatic cells.  
(A) Relative mRNA expression of integrin receptors in human fetal pancreatic cells 
cultured for 1 week with fibrin or on TCPS. (B) Representative western blots for β1, αv 
and β3 integrin expression. Quantitative analysis of integrins αv (C) and β3 (D) in human 
fetal pancreatic cells during the culture period. Data are expressed at means ± SE (n=3-5). 
*p<0.05, **p<0.01 and ***p<0.001 vs. TCPS control. 
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5.3.6 Subcutaneous transplantation of cultured human fetal islet-
epithelial cell clusters with fibrin maintained insulin and 
glucagon expression and improved vascularization 
Human fetal islet-epithelial cell clusters were cultured in 3D fibrin or 3D collagen for 1 
week, then transplanted subcutaneously into nude mice to investigate the potential of either 
ECM protein to promote differentiation and vascular formation. As controls, empty fibrin 
and empty collagen were cultured and transplanted adjacently. Grossly, transplantation of 
fibrin-cultured cells led to a graft with vessels surrounding it, while an empty fibrin graft 
can be observed immediately next to it, with markedly less vascularity (Fig. 5-6A left). 
Conversely, cells cultured with collagen and then transplanted led to a graft with less 
vascularity, very similar to both the empty fibrin and empty collagen grafts (Fig. 5-6A 
right). Double immunofluorescence staining of insulin and glucagon was similarly 
maintained in fibrin and collagen after 7 days of culture. However, after 1 week 
subcutaneous transplantation, the fibrin group had slightly more insulin and glucagon 
immunoreactivity than cells cultured and transplanted with collagen (Fig. 5-6B top row). 
Cells cultured and transplanted with fibrin also had maintained expression of CK19, which 
was lost in the collagen grafts (Fig. 5-6B 2nd row). Cell proliferation in the transplanted 
groups was also maintained compared to the groups after 7 days in culture (Fig. 5-6B 3rd 
row). Finally, blood vessels were prominent and elongated, similar to native pancreatic 
vessels, when fibrin-cultured human fetal islet-epithelial cell clusters were transplanted 
compared to the collagen group (Fig. 5-6B 4th row). 
5.4 Discussion 
This study investigated how fibrin can promote differentiation and proliferation of human 
fetal islet-epithelial cell clusters in vitro and in vivo. The native human fetal pancreas 
contains many ECM proteins, including fibronectin that may associate with integrin αvβ3. 
Culture of human fetal pancreatic cells in 2D and 3D fibrin for one week significantly 
increased PDX-1, insulin and glucagon expression. This was associated with up-regulation 
of integrins αv and β3, VEGFA, phosphorylated FAK and phosphorylated p70s6k. The   
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Figure 5-4 PDX-1 expression is regulated by mTOR signaling pathway activity.  
Quantitative analysis of phosphorylated FAK (A), AKT (B), ERK1/2 (C) and p70s6k (D) in 
human fetal pancreatic cells during the culture period. Western blot analysis of 
phosphorylated p70s6k (E), PDX-1 (F) and cyclin D1 (G) expression, and (H) 
immunofluorescence staining of Ki67 in 2D fibrin-cultured pancreatic cells with or without 
rapamycin treatment. Arrows indicate proliferating cells, scale bar: 50μm and nuclei are 
stained by DAPI (blue). Data are expressed at means ± SE (n=3-5). Representative blots 
are shown. *p<0.05, **p<0.01 and ***p<0.001 vs. TCPS control. p: phosphorylated; t: 
total. 
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reduction in p70s6k phosphorylation by rapamycin treatment led to significant decreases in 
PDX-1 expression and cell proliferation. Subcutaneous injection of fibrin mixed with 
human fetal islet-epithelial cell clusters into nude mice showed remarkable vascularization 
compared to collagen controls. We extended these results by subcutaneously transplanting 
pre-cultured human fetal islet-epithelial cell clusters with fibrin, which led to maintained 
expression of insulin and glucagon, but also more pronounced vascularization in the graft 
compared to collagen. This study shows that fibrin can maintain human fetal islet-epithelial 
clusters and enhance vessels formation in vitro and in vivo.  
Robust ECM proteins are present in the developing human pancreas along with integrin 
αvβ3. Previous studies have indicated the presence of multiple integrin receptors in the 
human fetal pancreas, which bind to the ECM to mediate cellular responses [14]. In 
particular, integrin β1 stimulates FAK and ERK1/2 to promote human islet-epithelial cell 
differentiation and survival [18]. Alongside, human islet development requires integrins 
αvβ3 and αvβ5 [17] and integrin αvβ1 [16] for adhesion and migration of cells. In mice, 
the ECM component laminin-1 promotes differentiation of pancreatic beta cells [31], likely 
through α6 integrin [32]. Culture of beta cells in hydrogels with ECM proteins improves 
survival and function [33]. However, loss of beta cell phenotype including diminished 
insulin expression occurs during long-term culture [34, 35]. In current study, fibrin culture 
of human islet-epithelial cells replaced, at least in part, the ECM lost during pancreatic 
dissociation. This led to improved expression of integrin receptors, signaling molecules 
and differentiation of islet cells. 
The present study demonstrated that culture of human fetal islet-epithelial cell clusters with 
fibrin increased the expression of integrins αv and β3 and downstream activity of FAK and 
p70s6k signaling molecules. Many integrin receptors on different cell types have been 
shown to bind fibrin, including integrins αvβ3 and αIIbβ3 [36]. We have recently shown 
that fibrin-culture of INS-1 cells increased expression of integrins αv and β3, but not β1 
[24]. These results support the notion that stimulation of integrins with ECM can promote 
cellular expression and activation of downstream signaling pathways [12, 24]. At one week 
of culture, no differences in signaling pathway activity changes were observed. However,  
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Figure 5-5 Subcutaneous injection of human fetal pancreatic cells with fibrin improves 
vasculature.  
Gross demonstrations of subcutaneously injected human fetal pancreatic cells mixed with 
fibrin (A) or collagen (B) in low (left) and high (right) magnification. (C) Histological 
image of control empty injections of fibrin and collagen. (D) Double immunofluorescence 
labeled human fetal pancreatic cells either before injection (left column) or after 1 week in 
vivo with fibrin (middle column) or collagen (right column). Cells were stained with 
insulin (red)/ glucagon (green) (top row), SOX9 (red)/ CK19 (green) (2nd row), Ki67 (red)/ 
human mitochondrial surface protein (HMS, green) (3rd row) and CD31 (red)/ HMS (green) 
(4th row). Representative images are shown with DAPI staining the nuclei (blue). Black 
arrows point to graft location, while white arrowheads indicate donor derived blood 
vessels. Scale bars: 50μm 
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there was a trend towards increasing pathway phosphorylation in the fibrin-cultured group. 
A reason for this could be that, despite having significantly more integrin receptor 
expression, their activation did not reach a threshold to activate enough downstream 
signaling molecules to cause an effect. Yet, after one week of fibrin culture, the expression 
of insulin, glucagon and PDX-1 was increased, suggesting that these markers were being 
modulated by molecules other than integrins, AKT and ERK1/2.  
Aberrant mTOR pathway signaling occurs in multiple diseases states [37]. We observed 
significant increases in phosphorylated p70s6k when human fetal pancreatic cells were 
cultured with fibrin, which was AKT-independent (Fig. 5-4). Despite many studies 
confirming that the mTOR pathway relies upon AKT, research in a pancreatic beta cell line 
(INS-1) showed that beta cell proliferation mediated by active mTOR/p70s6k signaling is 
AKT-independent [38, 39]. We expand on these results, suggesting that mTOR activity 
was stimulated without active AKT to modulate differentiation of human fetal pancreatic 
ells. However, leucine stimulation of the mTOR pathway in fetal rat pancreatic cells led to 
inefficient differentiation of Pdx-1 positive cells into neurogenin-3 positive cells [40]. This 
finding suggests that mTOR activity has a negative effect on pancreatic differentiation. The 
major difference between our study and previous research is the use of human cells. 
Numerous articles have outlined signaling pathway differences between the rodent and 
human pancreas [41-43]. Also, the mTOR pathway has different effects on islet cell cycle 
depending on animal species [44, 45]. In particular, stimulation of rodent islets with 
palmitate led to increased DNA synthesis (in an mTOR-dependent manner) in rodent islets, 
but not those isolated from humans [45]. Therefore, mTOR pathway activity may have 
different effects on islet cell differentiation based on whether cells are human or rodent. 
Our results suggest that the mTOR pathway has a positive effect on differentiation and 
proliferation of human fetal pancreatic cells when these cells were cultured with fibrin. 
When human fetal islet-epithelial cell clusters were cultured with fibrin, we observed 
significant increases in VEGF-A expression (Fig. 5-2). We also observed robust vascular 
presence when cells were transplanted with fibrin. Two transplantation methods are used 
in the current study: (1) transplantation of human fetal islet-epithelial cell clusters with 
fibrin just after polymerization initiation and (2) one week culture of cells in fibrin then   
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Figure 5-6 Subcutaneous transplantation of fibrin-cultured human fetal pancreatic cells 
maintains expression of insulin, glucagon, CK19 and improves vasculature.  
(A) Human fetal pancreatic cells cultured for 1 week with fibrin (left) or collagen (right) 
then transplanted subcutaneously into nude mice with an empty gel for 1 week. E represents 
the empty gel, while G is the graft. (B) Double immunofluorescence staining of human 
fetal pancreatic cells after 1 week of 3D culture with fibrin (left column) or collagen (2nd 
column); or after 1 week culture and 1 week post-transplantation in nude mice (fibrin – 3rd 
column, collagen – 4th column). Cells were stained for insulin (red)/ glucagon (green) (top 
row), SOX9 (red)/ CK19 (green) (2nd column), Ki67 (red)/ HMS (green) (3rd column) and 
CD31 (red)/ HMS (green). Representative images are shown with DAPI staining the nuclei 
in blue. Scale bars: 50μm. 
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transplantation of the combination subcutaneously for one week. Both of these experiments 
demonstrated that transplanted fibrin-wrapped human fetal islet-epithelial cell clusters 
could promote vasculature formation and maintain cell differentiation and proliferation. 
Previous reports indicate that culturing human adult islets in fibrin for one week followed 
by transplantation of the cells resulted in improved graft size, reduced ductal structures and 
significantly increased c-peptide levels compared to animals that received free-floating  
cultured islets [25]. It was postulated that the angiogenic-promoting effects of fibrin are 
what led to such results. These effects have also been observed when a fibrin hydrogel-
islet composite was subcutaneously transplanted in mice [46]. Fetal porcine islet-like cell 
clusters were transplanted under the kidney capsule of nude mice and sufficient 
angiogenesis occurred to develop an autonomous microcirculation supporting these islet-
like clusters [47]. Likewise, normalization of glycemia occurred when fibrin-encapsulated 
VEGF-treated rat islets were transplanted into diabetic mice [48]. Results from these 
studies in combination with our own confirm that blood vessel formation is important for 
the maintenance of islet graft function and survival.  
Fibrin has been used in many tissue-engineering specialties as a carrier [49, 50]; however, 
as an encapsulation vehicle for islet transplantation, fibrin has not been well characterized. 
Encapsulating rat islets with fibrin, then transplanting them into diabetic nude mice 
normalized glycemia with a minimum of only 100 islet equivalents [51]. Another study 
found that transplantation of islets in a fibrin glue reduced diabetic mouse blood glucose 
to normal levels [30]. Our results show that human fetal pancreatic cells can be cultured 
with fibrin and transplanted to yield a successful graft. Taken together, fibrin may be used 
as a microencapsulation scaffold for islet transplantation to enhance outcomes.  
5.5 Conclusions 
The human fetal pancreas contains rich ECM fibers and expression of integrin αvβ3. Fibrin 
improves human fetal pancreatic cell differentiation via the mTOR pathway that is 
associated with increases in integrin αvβ3 expression. Fibrin also improves graft 
vascularization when human fetal pancreatic cells are transplanted subcutaneously with or 
without a pre-culture period. Understanding how fibrin promotes human pancreatic 
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progenitor differentiation will enhance existing protocols that aim to generate functional 
beta cells for the treatment of diabetes. 
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Chapter 6  
6 General discussion, limitations and future direction 
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6.1 Summary of discussion 
Integrin-ECM interactions mediate a variety of cellular processes in the pancreas. The goal 
of this thesis was to investigate the role of β1 integrin in the adult murine pancreas and the 
role of fibrin-integrin interactions in support of pancreatic cell function, proliferation, 
survival and maturation.  
My first and second objectives were to investigate the in vivo role of β1 integrin on the 
murine pancreas. Primary loss of β1 integrin on pancreatic stellate and beta cells had a 
detrimental effect on ECM expression and tissue architecture. As well, a decrease in 
pancreatic β1 integrin expression occurred, which was associated with glucose intolerance, 
significantly reduced protein levels associated with exocrine tissue function and decreased 
FAK/MAPK/ERK1/2 signaling pathway activity. Importantly, loss of β1 integrin led to 
significantly decreased pancreatic cell proliferation and increased cell death.  
The significance of this work lies in the clinical relevance for cell-based therapies for 
diabetes treatments. As mentioned previously, islet transplantation requires isolation of 
islets from the donor pancreas. The process of islet isolation destroys connections between 
the ECM and integrin receptors, which I have shown to be essential for pancreatic cell 
integrity. In particular, the loss of islet cell-cell and islet cell-endothelial cell, and islet cell-
basement membrane connections leads to progressive loss of insulin expression and 
increased cell death [1, 2]. The combination of these consequences leads to low quality 
islets for transplantation and increases the susceptibility of graft failure. To avoid this, 
transplanting islets immediately after isolation is ideal in order to re-establish islet cell 
contacts with surrounding cells or ECM. However, this removes all opportunities to expand 
beta cells in vitro, which has been met with limited success due to the high incidence of 
cell death. For this reason, researchers have been culturing islets with various stimulating 
factors or ECM proteins in an attempt to improve in vitro islet health and expand beta cells. 
My third and fourth objectives were to investigate the role of fibrin-integrin interactions in 
support of pancreatic cell function, proliferation, survival and maturation. Culturing INS-
1 cells with fibrin significantly increased integrin αvβ3 expression, improved GSIS, and 
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prevented cell death through integrin αvβ3. Meanwhile, when human fetal pancreatic cells 
were cultured with fibrin, significant increases in islet gene expression occurred, including 
increased expression of integrin αvβ3, phosphorylated FAK and phosphorylated p70s6k. 
Subcutaneous injection of human fetal pancreatic cells wrapped in fibrin led to robust 
vascularization compared to collagen. 
Previous studies have cultured pancreatic islets in a variety of other ECM matrix proteins, 
in an attempt to recapitulate the native pancreas environment. However, culturing islets in 
these conditions leads to either cystic formation [3], transdifferentiation [4], or loss of 
function [5]. It appears that without stimulation of a variety of cell surface receptors, islets 
are doomed to a less-than-ideal fate. Indeed, when islets are cultured with multiple ECM 
proteins or matrigel (a gel derived from tumor cells), islet cells have improved insulin 
secretion [6, 7]. Therefore, ensuring stimulation of cell surface receptors after islet 
isolation, especially integrins, is critical to maintain or expand beta cells in vitro. Fibrin 
was able to support mature beta cells with respect to function, proliferation, and survival. 
There were also improvements to pancreatic progenitor differentiation when human fetal 
islet-epithelial clusters were cultured with fibrin. These effects were, in part, mediated by 
fibrin’s binding to integrin receptors. However, to obtain ideal maintenance of islet cell 
health, it is likely that a combination of factors and ECM proteins are required during 
culture. 
When pancreatic cells were cultured with fibrin, integrin αvβ3 was increased with no 
change in other integrin receptor expression, such as β1. It has been previously mentioned 
that fibrin contains RGD domains that preferentially bind to integrin αvβ3. However, the 
mechanism by which integrins mediate their own specific expression is not clear. Cells are 
able to make their own ECM matrix, which may autostimulate receptors for continued 
survival [8]. This feedforward mechanism may stimulate integrin receptor expression, 
noted in fibroblasts [9, 10]. This, however, does not explain why only certain integrin 
receptors had increased expression and others did not.  
The non-receptor tyrosine kinase, FAK, had significantly decreased activity in mice 
lacking β1 integrin, and significantly increased activity in pancreatic cells cultured with 
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fibrin suggesting that FAK is a mediator of integrin activation. Indeed, mice lacking beta 
cell-expression of FAK had reduced viability and function due to FAK signaling pathway 
down-regulation and impaired cytoskeletal dynamics [11]. The level of FAK 
phosphorylation is correlated to beta cell survival, due to either cyclin-dependent kinase 5 
activation [12] or after ECM culture [13]. In this way, the deleterious effects of β1 integrin 
loss and beneficial effects of fibrin culture may be mediated through FAK activation.  
6.2 Limitations 
Common to all basic science research are the limitations associated with the use of animal 
models as surrogates for humans. Rodents are the primary animal used in the studies 
presented here and despite sharing a large percent of their DNA with humans, significant 
differences exist. Above all, the organization of pancreatic islets differ, with significantly 
more alpha cells being in contact with beta cells in humans compared to mice [14]. As well, 
the glucose-induced electrical activity and insulin release of beta cells is significantly 
different between mice and humans [15]. These differences should be considered when 
translating these studies to humans. 
One limitation of the conclusions drawn from Chapter 2 and 3 is that the promoter used to 
control Cre recombinase expression has activity in multiple cell types. The β1 integrin 
knockout mouse model used here has Cre expression restricted to cells that express 
collagen 12. Staining for β-galactosidase showed immunoreactivity in islets and stellate 
cells, with an eventual loss of β1 integrin in most of the pancreas. Despite this latency, 
mice lacking β1 integrin developed significant blood glucose dysregulation associated with 
decreased beta cell mass, improper insulin secretion, and reduced FAK/MAPK/ERK1/2 
signaling pathway activity. A recently published study demonstrated that beta cell specific 
knockout of β1 integrin using the rat insulin promoter showed significantly reduced beta 
cell mass [16]. This suggests that the lack of specificity of Cre expression, in our mouse 
model, did not dramatically affect the islet phenotype observed here. However, since β1 
integrin loss in the current study was not specific to beta cells, secondary effects that might 
explain the findings presented here cannot be ruled out. 
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The main limitation of Chapter 4 is the use of the INS-1 cell line as a surrogate for primary 
adult beta cells. This cell line is derived from rat insulinoma cells and has been 
immortalized. It is reminiscent of normal beta cells with respect to propensity to form 
clusters, secrete insulin in response to glucose, and express the majority of beta cell-
associated transcription factors. However, it has significant genetic alterations that render 
it categorically different than primary beta cells isolated from mice and especially humans. 
Finally, two important limitations must be considered for Chapter 5. The first is the use of 
human samples, which have dramatic diversity between individuals. Inbred mice have 
minimal inherent differences because they are nearly genetically identical, whereas tissue 
obtained from different humans have a wide range of gene expression and DNA 
composition. This causes each human biological replicate to behave differently to stimuli. 
In the laboratory, this leads to data that is largely insignificant unless a biological replicate 
number is high enough. Another limitation of our studies using human fetal pancreatic 
tissue is the timing of sample acquisition. We restricted our studies to the 15-21 week old 
fetal pancreas, but may have observed more profound effects if we restricted our time point 
to only a single week, or used one later in development. Unfortunately, there is a significant 
lack of human fetal pancreata for research purposes, which leads to skewed data.  
6.3 Future direction 
The studies associated with this thesis do not present an entire story. The field of islet 
biology with respect to cell adhesion receptors has much to be discovered in order to 
improve upon current islet transplantation techniques. 
To improve upon the first study presented in Chapter 2, future experiments should use mice 
with an inducible Cre-loxP system where the β1 integrin gene is floxed and Cre expression 
is restricted to beta cells of the pancreas. Mice are commercially available that have 
tamoxifen-inducible Cre expression regulated by the mouse insulin promoter. Crossing this 
mouse with the floxed β1 integrin mouse would yield mice that only lose β1 integrin 
expression in beta cells after tamoxifen injection. This prevents any confounding factors 
and better elucidates the direct role of β1 integrin in the developed endocrine pancreas. 
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Alongside, it will be beneficial to isolate islets from these mice and perform in vitro GSIS 
tests on them. This experiment determines the primary defect in islets and whether or not 
it is due to dysfunctional insulin secretion. 
Future studies for Chapter 3 of this thesis should include use of a mouse model that has 
Cre expression specified to acinar cells of the exocrine pancreas. Promoters such as 
amylase or carboxipeptidase-A would specify β1 integrin loss to pancreatic acinar cells, 
and thus allow investigation of the direct effects of β1 integrin deficiency. 
To further investigate the results of Chapter 4, the use of primary adult beta cells or islets 
isolated from rodents or humans would generate more representative data. As well, it would 
be of great interest to transplant fibrin-cultured adult beta cells or islets into diabetic mice, 
to investigate the effects of long-term culture on the in vivo function of endocrine cells.  
Finally, future studies for Chapter 5 should focus on increasing the replicate number to 
ensure the data is a true representation of the human population. Alternatively, sorting cells 
into various different cell populations before culture would allow for more precise data 
collection since the effects of fibrin may be specific to cells expressing αvβ3. Alternatively 
to cell sorting, experiments should use specific differentiation media that drive progenitor 
cells towards islet-specific gene expression during fibrin culture. These effects could then 
be analyzed in vivo by transplanting cells into diabetic mice. 
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Appendix 4 Antibodies used for experiments 
Primary antibody Dilution Company, Location 
Mouse anti-actin 
Rabbit anti-AKT 
Mouse anti-AKT (phospho-Ser473) 
Mouse anti-amylase 
Mouse anti-calnexin 
Mouse anti-carboxypeptidase A 
Mouse anti-caspase-3 
Mouse anti-cleaved caspase-3 
Mouse anti-cyclin D1 
Mouse anti-cytokeratin 19 
Rabbit anti-ERK1/2 
Rabbit anti-ERK1/2 (phospho-
Thr202/Tyr204) 
Rabbit anti-FAK 
Rabbit anti-FAK (phospho-Tyr397) 
Rabbit anti-β-galactosidase  
Mouse anti-GFAP 
Rabbit anti-glucagon 
Mouse anti-human mitochrondrial 
surface protein 
Guinea pig anti-insulin 
Rabbit anti-Ki67 
Mouse anti-laminin 
Mouse anti-nkx6.1 
Rabbit anti-p70s6k 
Rabbit anti-p70s6k (phospho-Thr389) 
Rabbit anti-pdx-1 
1:5000 
1:1000 
1:1000 
1:1000 
1:1000 
1:1000 
1:1000 
1:1000 
1:1000 
1:100 
1:1000 
1:1000 
 
1:2000 
1:2000 
1:100 
1:100 
1:100 
1:50 
 
1:50 
1:200 
1:50 
1:100 
1:1000 
1:1000 
1:1500 
Sigma; St. Louis, MO, U.S.A. 
Cell Signaling; Temecula, CA, U.S.A. 
Cell Signaling; Temecula, CA, U.S.A. 
Santa Cruz; Santa Cruz, CA, U.S.A. 
BD Biosciences; Mississauga, ON, CA 
AbD serotec; Raleigh, NC, U.S.A. 
Cell Signaling; Temecula, CA, U.S.A. 
Cell Signaling; Temecula, CA, U.S.A. 
Cell Signaling; Temecula, CA, U.S.A. 
Dako; Glostrup, DEN 
Cell Signaling; Temecula, CA, U.S.A. 
Cell Signaling; Temecula, CA, U.S.A. 
 
Cell Signaling; Temecula, CA, U.S.A. 
Abcam; Cambridge, MA, U.S.A. 
Abcam; Cambridge, MA, U.S.A. 
Pharmingen; Mississauga, ON, CA 
Santa Cruz; Santa Cruz, CA, U.S.A. 
Millipore; Billerica, MA, U.S.A. 
 
Zymed; San Francisco, CA, U.S.A. 
Abcam; Cambridge, MA, U.S.A. 
DSHB; Iowa City, IO, U.S.A. 
DSHB; Iowa City, IO, U.S.A. 
Cell Signaling; Temecula, CA, U.S.A. 
Cell Signaling; Temecula, CA, U.S.A. 
Dr. Christopher Wright; University of 
Vanderbilt, Nashville, TN, U.S.A. 
Rabbit anti-PECAM-1 1:100 Santa Cruz; Santa Cruz, CA, U.S.A. 
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Mouse anti-reg-II 
Rabbit anti-SOX9 
Rabbit anti-αv integrin 
Rabbit anti-β3 integrin 
1:1000 
1:50 
1:1000 
1:1000 
R&D System; Minneapolis, MN, U.S.A. 
Abcam; Cambridge, MA, U.S.A. 
Abcam; Cambridge, MA, U.S.A. 
Abcam; Cambridge, MA, U.S.A. 
Rabbit anti-β1 integrin 
Goat anti-β1 integrin 
1:1000 
1:150 
Millipore; Billerica, MA, U.S.A. 
R&D Systems; Minneapolis, MN, U.S.A. 
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Appendix 5 Primers used for experiments 
Primer Name Accession & 
Definition 
Primer Sequence Size (bp) 
Amy1 
 
Col1a1 
 
Col1a2 
 
Fn1 
 
GLUCAGON 
 
INSULIN 
 
Insulin I   
 
Insulin II   
 
ITGA3 
 
Itga3 
 
ITGA5 
 
Itga5 
 
Itga8 
 
ITGAV 
 
NM_007446.2 
 
NM_007742.3 
 
NM_007743.2 
 
NM_101233.1 
 
NM_002054.2 
 
NM_000207.1 
 
NM_019129.1 
 
NM_019130.1 
 
NM_002204.1 
 
NM_001108292.1 
 
NM_002205.2 
 
NM_001108118.1 
 
NM_001173972.1 
 
NM_002210.2 
 
F: 5’- CAA GTG GAG GTA TCG AGA AC -3’ 
R: 5’- CCC TGC TAC GCC AAT GTC AA -3' 
F: 5’- CCT CCC AGT GGC GGT TAT GAC -3’ 
R: 5’- GGG TTC GGG CTG ATG TAC CAG -3’ 
F: 5’- AGG GTG AAA CTG GTC TCC GA -3’ 
R: 5’- CCC TCC ATC ACC ACG ACT TC -3’ 
F: 5’- AAC TAC GAT GCC GAT CAG AA -3’ 
R: 5’- CCC TCC TCG TGA CGC TGG TG -3’ 
F: 5’- GAT GAA CGA GGA CAA GCG CC -3’ 
R: 5’- CCT TTC ACC AGC CAA GCA AT -3’ 
F: 5’- TAC CTA GTG TGC GGG GAA CG -3’ 
R: 5’- CTG CGG GCT GCG TCT AGT TG -3’ 
F: 5’- ACA CCC AAG TCC CGT CGT GA -3’ 
R: 5’- TGA TCC ACA ATG CCA CGC TT -3’ 
F: 5’- ATG GCC CTG TGG ATC CGC TT -3’ 
R: 5’- TGC CAA GGT CTG AAG GTC AC -3’ 
F: 5’- AGA TGC GGG CAG CCT TCG TG -3’ 
R; 5’- GTT TTC ATG CCA GAC TCA CC -3’ 
F: 5’- CTG CTA GTA GGG AGC CTG TCG  -3’ 
R: 5’- TGT CAG CCT CCA CTG TGT AAG -3’ 
F: 5’- GGC CAG CCC TAC ATT ATC AG -3’ 
R: 5’- GGT TCA CGG CAA AGT AGT CA -3’ 
F: 5’- ACC AGA GCA AGA GCC GGA TAG -3’ 
R: 5’- GGT TCA CCG CGA AGT AGT CA -3’ 
F: 5’- CCC GTG TCT CTG GCG TTC AA  -3’ 
R: 5’- GAT ATC CGG CTG GCT AGT GT  -3’ 
F: 5’- GGA GCA ATT CGA CGA GCA CT -3’ 
R: 5’- ACT AAT GTT AGC AGG CGT GA -3’ 
149 
 
383 
 
373 
 
263 
 
240 
 
229 
 
131 
 
243 
 
484 
 
223 
 
303 
 
288 
 
162 
 
246 
 
 157 
 
ItgaV 
 
ITGB1 
 
Itgb1 
 
ITGB3 
 
Itgb3 
 
Itgb5 
 
Lama1 
 
Lamb1 
 
Lamc1 
 
PDX1 
 
Pdx1 
 
18S 
NM_001106549.1 
 
NM_002211.2 
 
NM_017022.2 
 
NM_000212.2 
 
NM_153720.1 
 
NM_47139.2 
 
NM_008480.2 
 
NM_010721.2 
 
NM_010683.2 
 
NM_001108292.1 
 
NM_022852.3 
 
NR_046237.1 
F: 5’- TTA TGC CAA AGA TGA CCC ACT  -3’ 
R: 5’- CGG GAC CTC CAA GAA GTA CTC  -3’ 
F: 5’- AGA GAG CTG AAG ACT ATC CCA T -3’ 
R: 5’- CGC TGT TTT CCA ACA AGT TC -3’ 
F: 5’- GTT GGT CAG CAG CGC ATA TC -3’ 
R: 5’- GCC CAC TGC TGA CTT AGG AA -3’ 
F: 5’- AAG ATT GGA GAC ACG GTG AG -3’ 
R: 5’- AGT ACT TGC CCG TGA TCT TG -3’ 
F: 5’- TGG CAA GAT CAC CGG CAA GT  -3’ 
R: 5’- CAG TCC GAG TCA CAC ACG CA -3’ 
F: 5’- TGG TGT TCA CGA CGG ACG AC  -3’ 
R: 5’- AGC AAG GCA AGC GAT GGA TA  -3’ 
F: 5’- GGC GGT ATA ACA ACG GAA CC -3’ 
R: 5’- GCA ATC CAC CCA CGT AAA TC -3’ 
F: 5’- CGA GAG TAT GAG GCG GCA CT -3’ 
R: 5’- CAC TTC CAC CAA GCG GGT CT -3’ 
F: 5’- TAG CCA AAT TAG CCG ACT GC -3’ 
R: 5’- GCT CCC TGG AGG CGA TCT CA -3’ 
F: 5’- CTG CTA GTA GGG AGC CTG TCG -3’ 
R: 5’- TGT CAG CCT CCA CTG TGT AAG -3’ 
F: 5’- GGC TTA ACC TAA ACG CCA CA -3’ 
R: 5’- AGA GTC CCA GAG GCA GAC CT -3’ 
F: 5’- GTA ACC CGT TGA ACC CCA TTC -3’ 
R: 5’- CCA TCC AAT CGG TAG TAG CG -3’ 
287 
 
313 
 
369 
 
 
 
120 
 
148 
 
180 
 
285 
 
122 
 
223 
 
175 
 
151 
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